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Resumo 
Ataxia-telangiectasia mutada (ATM) é uma cinase que desempenha funções chave na 
sinalização da ativação de vias de reparação do DNA e de resposta ao stress oxidativo, entre 
outras. Mutações em ATM levam ao desenvolvimento de ataxia-telangiectasia (A-T), uma doença 
caracterizada por exemplo por ataxia, imunodeficiências e desregulação do potencial redox.  
Malária é caracterizada por hemólise excessiva com acumulação de hemoglobina e heme 
no plasma, causando danos nos tecidos. Dados não publicados do laboratório anfitrião 
demonstraram que: i) ratinhos sem Atm são mais suscetíveis a malária do que ratinhos controlo, 
revelando uma nova doença onde Atm é essencial; ii) ratinhos controlo infetados com malária 
apresentam aumento da ativação das vias de reparação do DNA no baço, um órgão 
hematopoiético. Considerando estes dados, o principal objetivo do presente estudo é estudar a 
contribuição de Atm no compartimento hematopoiético para proteção contra a malária. Dados 
obtidos durante o presente estudo revelaram que ratinhos controlo tratados com heme, libertado 
no contexto da malária, mostram aumento da ativação das vias de reparação do DNA no baço, 
suportando uma possível função protetora de Atm no compartimento hematopoiético no 
desenvolvimento da malária. Para testar esta hipótese foram gerados e caracterizados ratinhos 
que apresentam uma deleção em Atm apenas neste compartimento, Vavicre/wtAtmΔ/Δ. Estes 
ratinhos são férteis e têm peso normal, ao contrário do observado em ratinhos Atm ko. Ratinhos 
Vavicre/wtAtmΔ/Δ infetados com malária revelaram ser mais suscetíveis que os ratinhos controlo, 
contudo, apresentam níveis de parasitas semelhantes, sugerindo que Atm tem um papel que não 
está associado à resistência contra o parasita causador de malária, mas protege de potenciais 
danos causados por este, um mecanismo designado de tolerância à doença. Este estudo 
representa um importante passo para a compreensão do papel de Atm no contexto da malária, 
podendo também ter implicações noutras doenças hemolíticas. 
 
Palavras-chave: Ataxia-telangiectasia mutada (ATM), heme, danos no DNA, compartimento 
hematopoiético, malária e tolerância à doença. 
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Abstract 
Ataxia-telangiectasia mutated (ATM) is a kinase that plays key roles in DNA repair signaling 
pathways and oxidative stress response, among others. ATM mutations lead to ataxia-
telangiectasia (A-T), a disease characterized for example by ataxia, immunodeficiencies and 
redox potential dysregulation.  
Malaria is characterized by excessive hemolysis with hemoglobin and heme being 
accumulated in plasma, causing tissue damage. Unpublished data from the host laboratory 
showed that: i) mice without Atm are more susceptible to malaria than controls, revealing a new 
disease where the presence of Atm is essential; ii) control mice infected with malaria show 
increased activation of DNA repair pathways in the spleen, a hematopoietic organ. Considering 
these data, the main objective of the present study is to address the contribution of Atm in the 
hematopoietic compartment in the protection against malaria. Data obtained during the present 
study showed that control mice treated with heme, released from cells in the context of malaria, 
show increased activation of DNA repair pathways in the spleen, supporting a possible protective 
function of Atm in the hematopoietic compartment in respect to malaria. To test this hypothesis, 
mice with Atm deletion exclusively in this compartment, Vavicre/wtAtmΔ/Δ, were generated and 
characterized. These mice are fertile and have normal weight, in contrast to Atm ko mice. Malaria-
infected Vavicre/wtAtmΔ/Δ mice were found to be more susceptible than control mice, but had similar 
levels of parasites, suggesting that Atm plays a role that is not associated with resistance against 
the malaria parasite, but protects against potential damage caused by it, a mechanism designated 
disease tolerance. This study represents an important step in understanding the role of Atm in 
the context of malaria and may also have implications for other hemolytic diseases. 
 
Key-words: Ataxia-telangiectasia mutated (ATM), heme, DNA damage, hematopoietic 
compartment, malaria and disease tolerance 
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Chapter 1. Introduction 
Resistance, a mechanism characterized by its impact on pathogen burden, is the most well-known 
defense mechanism against infection (McCarville and Ayres, 2018). However, in the recent years, 
researchers around the world have shown the importance of disease tolerance in the context of 
infection (McCarville and Ayres, 2018). Disease tolerance includes various mechanisms that have 
as a primary function the protection of the host against the deleterious effects caused by the 
presence of the pathogen without targeting directly the pathogen (Martins et al., 2019; McCarville 
and Ayres, 2018). In this case, the deleterious impact on the host is often a side effect of an 
attempt of the host to produce a hostile environment for the pathogen and cause its death. These 
extreme measures sometimes cause damage to the host itself (Chovatiya and Medzhitov, 2014; 
Martins et al., 2019; McCarville and Ayres, 2018; Soares et al., 2014). One example is the 
production of ROS as a result of the activation of pathogen killing mechanisms, which leads to 
DNA, protein and lipid oxidation (McCarville and Ayres, 2018; Medzhitov et al., 2012; Paiva and 
Bozza, 2014). On the other hand, the pathogen can cause stress and tissue damage, for example 
through the release of toxins or by inducing the lysis of host’s cells. Thus, disease tolerance 
mechanisms play a central role in protecting the host from the direct action of the pathogen 
(Medzhitov et al., 2012). 
Disease tolerance mechanisms include stress responses, such as responses to oxidative 
stress, or damage responses, such as DNA damage responses (Martins et al., 2019; Soares et 
al., 2014). Independently of the response, the goal is to limit the extent of damage as well as 
prevent and repair it to consequently control tissue damage, ensuring disease tolerance (Figure 
1.1 A). When these mechanisms and responses fail, the damage persists and disease develops, 
compromising the survival of the host (Figure 1.1 B) (Chovatiya and Medzhitov, 2014; Soares et 
al., 2014). Many proteins drive and regulate stress and/or DNA damage responses, and an 
example that is required in both types of responses is ATM (ataxia telangiectasia mutated) (Shiloh 
and Ziv, 2013). 
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Figure 1.1 Disease tolerance in the context of infection. 
(A) Upon infection, stress and damage responses are activated to counter the stress and damage caused 
by the pathogen and/or immune-driven mechanisms against the pathogen. When the repair is successful 
the tissue damage is controlled leading to disease tolerance. (B) When the stress and damage responses 
are not activated upon infection or repair fails, the damage caused by the parasite persists, leading to 
disease and possibly compromising host survival. 
 
1.1. Ataxia-telangiectasia mutated and disease in humans and mice 
ATM is a protein kinase involved in many pathways related to DNA damage repair (Ambrose and 
Gatti, 2013; Blackford and Jackson, 2017). Mutations in this protein are associated with the 
recessive autosomal disease ataxia-telangiectasia (A-T) (Blackford and Jackson, 2017). The 
most commonly observed features of this disease are neuronal degeneration, such as lack of 
coordination in voluntary movement (ataxia), and dilation of the blood vessels (telangiectasia) 
(Blackford and Jackson, 2017). A-T patients also present genomic instability, sensitivity to DNA-
damaging agents, such as radiation, and problems with lymphocyte development (e.g. V(D)J 
recombination and immunoglobulin class switching) , leading to immunodeficiency (Balestrini et 
al., 2016; Shiloh and Ziv, 2013). A-T patients are more susceptible to cancer, specially cancers 
types associated with the hematopoietic compartment (see section 1.6 ATM and the 
hematopoietic compartment), which is a direct consequence of all the changes at the molecular 
level in the immune cells, (Shiloh and Ziv, 2013). A-T patients also show elevated levels of 
oxidative stress (Kamsler et al., 2001; Reichenbach et al., 2002). 
The phenotype observed in humans with A-T is similar to the one described for mice lacking 
functional Atm, allowing for mouse models of the disease to be used to study ATM function and 
the pathways where it is involved (Barlow et al., 1996). The mouse Atm gene is localized in 
chromosome 9C, while the human homolog ATM is localized in the long arm of chromosome 11. 
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At nucleotide sequence level, human and mouse gene show an 85 % identity and at amino acid 
level 84 % identity (Pecker et al., 1996). 
To study A-T and ATM protein, mouse models of A-T have been generated. An Atm-
deficient mice was generated by disrupting the Atm gene with a PGKneo gene (Barlow et al., 
1996). Introducing this antisense construct at nucleotide position 5790 of Atm gene causes a 
frameshift mutation, resulting in a truncated and non-functional protein (Barlow et al., 1996).  
Fibroblasts isolated from Atm-deficient mice show cell cycle checkpoint abnormalities, 
namely in G1 phase, and poor growth (Barlow et al., 1996). These deficiencies in cellular growth, 
means that Atm-deficient mice have a smaller size at birth and weigh less than wild type (wt) and 
heterozygous mice during their lifetime. They also have neurologic abnormalities, although mice 
do not show signs of neurodegeneration or gross ataxia, as observed in A-T patients, most likely 
because they succumb to tumors before reaching the phase of neurodegeneration (Barlow et al., 
1996). Even though mice do not seem to have cerebellar degeneration, they have malfunction of 
the nigrostriatal pathways, age-dependent reduction in dopaminergic neurons, reduced synaptic 
function in hippocampal neurons and defective neural network (Shiloh and Ziv, 2013). Both male 
and female Atm-deficient mice are infertile, since they are not able to produce mature gametes 
due to problems in repairing double strand breaks (DSB) that occur during normal meiotic 
recombination to form both female and male gametes (Barlow et al., 1996; Coticchio et al., 2014; 
Rotman and Shiloh, 1998). Immunologic abnormalities and a higher probability of developing 
malignant thymic lymphomas are also characteristics of these Atm-deficient mice. Besides that, 
they have a much greater sensitivity to radiation. In terms of molecular effects, the Atm disruption 
causes chromosomal instability and defects in DSB repair, as observed in A-T patients (Barlow 
et al., 1996). 
 
1.2 ATM protein 
ATM is a kinase that can phosphorylate itself as well as other proteins, contributing directly and 
indirectly to the regulation of many pathways. Its gene has approximately 150 kb and 66 exons, 
codifying a 13 kb mRNA transcript and encoding a 350 kDa protein (Barlow et al., 1996) with 3056 
amino acid residues (Shiloh and Ziv, 2013). ATM protein localizes predominantly in the nucleus, 
but it can also be found in the cytoplasm and mitochondria (Ambrose and Gatti, 2013; Shiloh and 
Ziv, 2013; Valentin-Vega et al., 2012).  
ATM is part of the phosphoinositide 3-kinase (PI3K)-like protein kinase (PIKKs) family, 
which is also constituted by ATR (ATM and Rad3 related) and DNA-PK (DNA dependent protein 
kinase). The three kinases preferentially phosphorylate serine or threonine residues followed by 
glutamine (S/T-Q sites). In addition, all three share a similar structure constituted by a kinase 
domain and a PIKK regulatory domain in the C terminal region, flanked by a FRAP-ATM-TRRAP 
(FAT) domain and a FAT C-terminal motif (FATC). Between the N-terminal and the FAT domain, 
there are heat-repeats (HR) domains, with variable length, that mediate protein-protein and DNA-
protein interactions (Figure 1.2). ATM also has a leucine zipper region and substrate binding site 
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on the N-terminal region, as well as, a region that functions as an oxidative stress sensor within 
FATC domain (see section 1.4 ATM as an oxidative stress sensor and its targets) (Bhatti et al., 
2011; Blackford and Jackson, 2017). 
 
 
Figure 1.2 Ataxia-telangiectasia mutated structure. 
ATM is constituted by a kinase domain (KD, yellow) and a PIKK regulatory domain (PRD, light green) in the 
C terminal region, flanked by a FRAP-ATM-TRRAP (FAT, red) domain and a FAT C-terminal motif (FATC, 
blue). At the N-terminal region, ATM has a substrate binding domain (SBD, purple), heat repeats (HR, dark 
green) and a leucine zipper region (LZR, dark orange). Autophosphorylation site Ser1981 (#) and oxidative 
stress sensor site Cys2991 (*) are also represented. 
 
 
The three kinases are responsible for inducing cell cycle arrest and signaling DNA repair 
mechanisms in response to DNA damage (Blackford and Jackson, 2017). The choice of which 
pathway is activated depends on the type of damage and phase of the cell cycle.   
DNA-PK is recruited and activated in response to DSB and induces DNA repair by classical 
non-homologous end joining (C-NHEJ) (Blackford and Jackson, 2017). C-NHEJ consist in joining 
two blunt ends resulting from DSB, without requiring homology, and can occur at any phase of 
the cell cycle, but predominantly occurs in G1 and G2 (Ceccaldi et al., 2016).  
ATM is also recruited in response to DSB and can signal to induce repair through three 
mechanisms: C-NHEJ, by activating 53BP1 and histone H2AX which are involved in DNA-end 
protection, processing and bridging; homologous recombination (HR), by activating MRN, CtIP 
and BRCA1; and alternative end joining (alt-EJ), since MRN activation can also lead to repair via 
this mechanism (Figure 1.3) (Blackford and Jackson, 2017; Ceccaldi et al., 2016). HR consists 
in joining two resect ends and, in contrast to C-NHEJ, requires sequence homology, reason why 
it occurs predominantly in S/G2-phases of the cell cycle (Blackford and Jackson, 2017; Ceccaldi 
et al., 2016).   
ATR is more active in proliferating cells and is activated in response to various DNA 
damage types, particularly single strand breaks. ATR is involved in preventing replisome fork 
collapse and is more active in S-phase and G2/M phases, allowing repair by HR (Blackford and 
Jackson, 2017).  
Aside from being activated by DSB, more recent data have shown that ATM can also be 
activated in response to other stimuli, inducing other pathways unrelated with DNA repair but 
associated with stress responses (Ambrose and Gatti, 2013; Shiloh and Ziv, 2013). One example 
that will be discussed below is the activation of ATM by oxidative stress and the pathways induced 
through this type of activation (Guo et al., 2010a; Kozlov et al., 2016; Shiloh and Ziv, 2013).  
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1.3 ATM as a DNA damage sensor and its targets 
ATM can act as a DNA damage sensor that promotes DNA repair (Blackford and Jackson, 2017). 
ATM can phosphorylate substrates involved in many pathways, such as DNA repair, checkpoint 
activation, apoptosis, senescence, alterations in chromatin structure, transcription and pre-mRNA 
splicing, which explains its role in the regulation of different cellular mechanisms (Blackford and 
Jackson, 2017).  
DSB are probably the most deleterious form of DNA damage, and can occur due to 
endogenous insults, such as DNA replication or normal metabolism and development (e.g. V(D)J 
recombination and immunoglobulin class switching) or due to exogenous insults, such as ionizing 
radiation or chemical agents (Sancar et al., 2004).  
Upon DSB, ATM is recruited to these sites by interacting and binding to the C-terminus of 
NBS1 (Blackford and Jackson, 2017), which is a component of the MRE11-RAD50-NBS1 
complex (MRN complex or MRE11 complex) (Balestrini et al., 2016). RAD50 and MRE11 are 
responsible for the complex binding to DNA (Bhatti et al., 2011). After recruitment, ATM is 
catalytically activated so that it can phosphorylate other proteins (Figure 1.3). ATM can also 
phosphorylate itself in different residues, being some of them important for its activation (Shiloh 
and Ziv, 2013).  
One important step in the process of ATM activation is the transition from dimer to monomer 
(Bakkenist and Kastan, 2003). At steady state ATM is a noncovalently-associated homodimer, 
however, during the process of activation, it dissociates into active monomers (Ambrose and 
Gatti, 2013; Bakkenist and Kastan, 2003). Autophosphorylation on serine 1981 (Ser1981) is the 
most studied ATM autophosphorylation (Figure 1.2) (Blackford and Jackson, 2017), however its 
function and importance on ATM activation is still controversial. It was proposed that Ser1981 is 
important for ATM activation by helping this transition from inactive homodimer to active 
monomers (Bakkenist and Kastan, 2003). The hypothesis is that monomers of ATM are 
connected by binding its kinase domains to internal domains of other monomers which contributes 
to homodimer stabilization. Upon DNA damage, one monomer phosphorylates the Ser1981 of 
another monomer causing the dissociation of the complex. After the dissociation, the kinase 
domain is available to phosphorylate other substrates (Bakkenist and Kastan, 2003). Even though 
some studies support this hypothesis, others show that phosphorylation of Ser1981 is not 
essential for a normal ATM activation and DNA repair (Blackford and Jackson, 2017; Kozlov et 
al., 2011). 
Other key elements in this process of ATM activation are the sensor protein MDC1 and the 
histone H2AX. Histone H2AX is phosphorylated by ATM on Ser139 (Burma et al., 2001) and then 
interacts with MDC1 (Shiloh and Ziv, 2013), which binds to DSB sites and to ATM. This enables 
the recruitment of more ATM molecules, which then phosphorylate more H2AX promoting more 
MDC1 recruitment to DSB sites and subsequently more binding of ATM molecules. This positive 
feedback loop accelerates the process of ATM activation and reinforces DNA damage signaling 
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(Shiloh and Ziv, 2013). As mentioned before (see 1.2 ATM protein) H2AX is also important to 
induce the repair by C-NHEJ. 
Another important protein required for ATM activation is the phosphorylated form of TIP60 
acetyltransferase. TIP60, a tumor suppressor protein, is recruited to DSB sites and activated by 
interacting with histone H3, when it is trimethylated on lysine 9 (Lys9) (Sun et al., 2009). TIP60 
can be phosphorylated by c-Abl tyrosine kinase (Blackford and Jackson, 2017) and is responsible 
for the acetylation of ATM on Lys3016 that lies on to the FATC domain (Blackford and Jackson, 
2017; Shiloh and Ziv, 2013). Without the acetylation, ATM is not correctly activated which can 
lead to impaired DNA repair (Sun et al., 2009).  
 
 
Figure 1.3 Examples of ATM targets. 
ATM can phosphorylate many proteins in response to oxidative stress and DNA damage. H2AX and 53BP1 
are examples of ATM targets involved in DNA repair by non-homologous end joining; MRN, CtIP and BRCA1 
are examples of ATM targets involved in DNA repair by homologous recombination. LKB1 is an ATM target 
involved in metabolic stress regulation pathways; p53 and CHK2 are ATM targets that regulate cell cycle 
and finally HPS27 is an example of ATM target involved in the antioxidant pathways. These are some of the 
many proteins phosphorylated by ATM. 
 
 
After ATM activation by DSB, ATM can induce cell cycle arrest to enable damage repair 
via the regulation of checkpoint proteins from different phases of the cell cycle (Barzilai et al., 
2002; Blackford and Jackson, 2017). ATM can activate and stabilize p53, a tumor suppressor 
gene involved in the response to DNA damage and a master regulator of the G1/S checkpoint 
(Barzilai et al., 2002; Blackford and Jackson, 2017). The phosphorylation of p53 by ATM in 
multiple sites activates and stabilizes p53. As ATM can also phosphorylate other proteins involved 
in p53 stabilization and activation, it can also regulate p53 indirectly (Blackford and Jackson, 
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2017). Phosphorylation of Ser15 by ATM is the most studied phosphorylation of p53 and 
contributes to its stabilization by inhibiting the interaction with the ubiquitin ligase MDM2, which is 
also phosphorylated by ATM (Blackford and Jackson, 2017; Shiloh and Ziv, 2013). MDM2, also 
known as HDM2 in humans, is a negative regulator of p53 activation and an oncogene (Freedman 
et al., 1999). The overexpression of this protein was found in many types of cancer, including 
those on the hematopoietic compartment (Freedman et al., 1999). After activation and 
stabilization, p53 can influence cell fate, for example by inducing DNA repair and continuation of 
the cell cycle upon repair or by inducing cell death by apoptosis (Carvajal and Manfredi, 2013). 
Another important target of ATM is CHK2 (Blackford and Jackson, 2017). CHK2 is a kinase 
involved in cell cycle arrest. The major targets of CHK2 are p53, that is, as mentioned before, 
responsible to regulate cell fate, and members of Cdc25 family, responsible for cell cycle 
progression by dephosphorylating cyclin-dependent kinases (Ahn et al., 2004; Sancar et al., 
2004). Thus, phosphorylation of CHK2 on threonine 68 (Thr68) by ATM inhibits Cdc25 function 
causing cell cycle arrest  and also promotes further stabilization of p53 (Ahn et al., 2004; Blackford 
and Jackson, 2017; Sancar et al., 2004).   
Aside from being responsible for ATM recruitment, MRN complex can be phosphorylated 
by ATM to induce DNA repair by HR mostly in S-phase (Ceccaldi et al., 2016). Phosphorylation 
on Ser343 of NBS1 subunit by ATM is required for the cell cycle arrest, since mutations on Ser343 
prevent phosphorylation by ATM and cell cycle arrest (Lim et al., 2000). 
Another ATM target is BRCA1, a tumor suppressor that is involved in S-phase and G2/M 
checkpoints, as well as in DNA repair by HR (Ceccaldi et al., 2016; Xu et al., 2001). Depending 
on the phosphorylated site, BRCA1 can influence S-phase or G2/M arrest. Phosphorylation of 
Ser1423 by ATM is required for G2/M checkpoint but not for S-phase (Xu et al., 2001). On the 
other hand, phosphorylation on Ser1387 is just required for S-phase checkpoint (Xu et al., 2002). 
After successful DNA repair, it is necessary to inactivate the ATM network so that the cell 
can return to normal cell cycle (Shiloh and Ziv, 2013). One of the most important proteins involved 
in this inactivation is the type 2C phosphatase WIP1 (PPM1D). PPM1D reverts several ATM-
dependent phosphorylations, including that of p53 (Shiloh and Ziv, 2013). However, this 
inactivation of ATM network still needs further studies to be fully understood. 
 
1.4 ATM as an oxidative stress sensor and its targets 
Apart from its role in DNA repair, ATM can also be involved in responses to oxidative stress (Guo 
et al., 2010a; Shiloh and Ziv, 2013). Oxidative stress is a type of genotoxic stress that is linked to 
the formation of reactive oxygen species (ROS). ROS can be endogenous and result from normal 
metabolism, such as mitochondrial metabolism, or can be exogenous, such as ROS produced by 
xenobiotics (Yi et al., 1990). At the DNA level, ROS can cause DSB as well as base and/or sugar 
modifications (Gonzalez-Hunt et al., 2018; Sancar et al., 2004). For the first time, in 1990, the 
chromosomal instability in A-T patients was associated with oxidative stress and ROS (Yi et al., 
1990). Fibroblasts from A-T patients were shown to be more sensitive to treatment with hydrogen 
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peroxide than fibroblasts from healthy individuals and upon treatment revealed chromosomal 
instability and an increased number of micronuclei, a marker for DNA damage (Yi et al., 1990). 
This study supported the notion that ATM can have a role in the response to DNA damage caused 
by oxidative stress, raising the question whether ATM could be activated by the DNA damage 
that arises from ROS production or directly by oxidative stress. 
Over the last few years, different studies have shown that ATM can also be activated 
directly by oxidative stress, and so that it acts as an oxidative stress sensor (Guo et al., 2010a; 
Shiloh and Ziv, 2013). In this case, ATM activation is independent from the MRN complex and 
DSB formation and is associated with the cytoplasmatic and mitochondrial form of ATM (Shiloh 
and Ziv, 2013). When activation is driven by oxidative stress, instead of forming monomers, ATM 
dimerizes through disulphide bonds (Guo et al., 2010a; Shiloh and Ziv, 2013). Disulphide bonds 
are covalent ligations between two cysteine residues (Cys) (Wedemeyer et al., 2000). This 
modification is common in oxidative stress sensing proteins as a response to the environment 
oxidization and it is important to change the structure, activate and stabilize the protein (Cumming 
et al., 2004; Storz and Imlayt, 1999). ROS induces the formation of disulphide bonds by oxidizing 
specific cysteine residues on ATM, leading to changes in protein structure. (Guo et al., 2010a; 
Shiloh and Ziv, 2013). 
In 2010, a study demonstrated the importance of Cys2991 in ATM activation by oxidative 
stress (Figure 1.2) (Guo et al., 2010a). Using A-T lymphoblastoid cell lines, this study identified 
that mutation on Cys2991, present in the FATC domain, only compromised the activation of ATM 
by oxidative stress, but not its DNA repair function. Activation of ATM by oxidative stress can also 
be impaired in humans, without affecting ATM activation by DSB and the MRN complex, indicative 
of ROS direct activation of ATM (Guo et al., 2010a). Patients with an ATM variant characterized 
by the deletion of the last 10 amino acids of the FATC domain (R3047X mutation), a domain 
involved in the activation by oxidative stress, have less sensitivity to radiation when compared to 
other A-T patients and do not present with immunodeficiencies (Chessa et al., 1992; Gilad et al., 
1998; Guo et al., 2010a; Toyoshima et al., 1998). Thus, depending on the mutation, patients can 
exhibit features associated with a defective DNA damage response and/or associated with redox 
regulation (Guo et al., 2010a; Verhagen et al., 2009). 
In the case of activation by oxidative stress, autophosphorylation on Ser1981 is observed, 
but is not essential since mutations in this residue do not affect ATM activation in response to 
oxidative stress (Guo et al., 2010a).  
After the activation of ATM by oxidative stress, ATM phosphorylates other substrates to 
activate antioxidant pathways and DNA repair mechanisms (Figure 1.3). One important target of 
ATM in this context is heat-shock protein 27 (HSP27) (Cosentino et al., 2011; Zhang et al., 2018). 
The phosphorylation of HSP27 by ATM induces glucose-6-phosphate dehydrogenase (G6PD), 
which is an important protein for the pentose phosphate pathway (PPP). The PPP is a source of 
ribose-5-phosphate, the sugar present in the structure of nucleotides and essential to produce 
new nucleotides to consequently repair DNA damage, but also a source of NADPH (Cosentino et 
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al., 2011). NADPH is an endogenous antioxidant that intervenes in the glutathione pathway as a 
co-factor (Ditch and Paull, 2012). Previous studies associated the activation of PPP by ATM to 
the production of nucleotides to repair DNA damage as well as NADPH to regulate oxidative 
stress but without further evaluation regarding the mechanism of ATM activation in this context 
(Cosentino et al., 2011; Ditch and Paull, 2012). However, a study from 2018 (Zhang et al., 2018) 
showed a direct link between ATM activation by oxidative stress and the activation of PPP. This 
study demonstrated that cells with a mutation in the Cys2991 of the ATM gene, which 
compromises the activation by oxidative stress, have less activation of the PPP, suggesting that 
HSP27 is phosphorylated by ATM to activate antioxidant pathways, specifically PPP, and that 
ATM can function as a oxidative stress sensor protein. 
Another example of ATM phosphorylation following activation by oxidative stress is the 
phosphorylation of LKB1 tumor suppressor at Thr366 (Ditch and Paull, 2012). LKB1 activates 
AMP-activated protein kinase (AMPK), which in turn regulates cellular energy homeostasis and, 
by phosphorylating TSC2 tumor suppressor, inhibits mTORC1 (Ditch and Paull, 2012; Shiloh and 
Ziv, 2013). Regulation of mTOR by ATM activity, which occurs in response to oxidative stress, is 
described to regulate metabolic stress, enhance autophagy and to be involved in tumor 
suppression (Ditch and Paull, 2012; Shiloh and Ziv, 2013). 
 
1.5 ATM and the hematopoietic compartment 
A-T patients and Atm-deficient mice have immunodeficiencies and a higher probability of 
developing hematopoietic related cancers, such as lymphomas (Balestrini et al., 2016; Barlow et 
al., 1996), supporting the notion that ATM plays an important role in this compartment. In addition, 
deletion of the long arm of chromosome 11 at the ATM gene region is one of the most common 
genomic aberration found in lymphomas in general, which suggests that absence of ATM plays a 
role in the tumorigenesis process (Boultwood, 2001). Hematopoietic compartment includes the 
blood, spleen, thymus and bone marrow. As it will be discussed below, regulation of DNA repair 
and oxidative stress responses are essential for hematopoietic function. Thus, ATM activation 
both by DNA damage and oxidative stress is essential for a functional hematopoietic compartment 
(Balestrini et al., 2016; Ito et al., 2004; Liyanage et al., 2000; Maryanovich et al., 2012; Pan et al., 
2002; Vacchio et al., 2007). 
Previous studies have shown that ATM regulates V(D)J recombination and immunoglobulin 
class switching, two central pathways that allow the generation of immunoglobulin and/or T cell 
repertoire (Balestrini et al., 2016; Boultwood, 2001).  
The Ig (B cell receptors) and TCR (T cell receptors) genes encode different segments (V, 
D and J) that are cleaved and recombined (V(D)J recombination) to generate the diversity of 
antibodies and T cell receptors present in our immune system (Vacchio et al., 2007). The 
generation of B and T-cell receptors relies on inducing DNA breaks followed by recombination 
and repair (by NHEJ), a process that requires ATM (Vacchio et al., 2007). Analysis of tumors from 
Atm-deficient mice showed defects in T-cell development, such as rearrangement of chromosome 
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14, where the T-cell receptor α (Tcrα/δ) locus is located, and translocations involving chromosome 
12 at Tcl1 oncogene locus (Liyanage et al., 2000). The same chromosomal aberrations in the 
homologous genes and chromosomes in humans, and associated B and T-cell development 
problems, are observed in A-T patients (Liyanage et al., 2000; Vacchio et al., 2007). Atm-deficient 
mice show reduction in mature CD4 and CD8 single-positive T cells and increased immature 
double-positive T cells when compared to wild type mice (Barlow et al., 1996; Vacchio et al., 
2007) and reduction in Tcr rearrangements (Vacchio et al., 2007), supporting the notion that 
absence of Atm affects T cell maturation. 
In addition to V(D)J recombination, B cells can also undergo class switch recombination 
(CSR). CSR is characterized by genetic alterations in the loci that codify the antibodies’ constant 
region, allowing the expression of antibodies that recognize the same antigen but with different 
constant regions and effector functions (Dudley et al., 2005). As in V(D)J recombination, in CSR 
the genetic alterations are related with DSB that can be repaired by ATM (Pan et al., 2002). 
Analysis of CSR using spleens from mice that lack Atm in the hematopoietic compartment 
revealed defects in repair of DSB necessary for immunoglobulin class switch recombination, and 
lower levels of IgG when compared to those in wild type mice (Balestrini et al., 2016). Analysis of 
CSR in A-T patients revealed that these patients show aberrant switch junctions (Pan et al., 2002) 
It was proposed that ATM also has a role on self-renewal of hematopoietic stem cells (HSC) 
by controlling the redox homeostasis (Ito et al., 2004). By transplanting bone marrow cells from 
Atm-deficient mice into congenic recipients, an in vivo study showed that Atm-deficient bone 
marrow cells have impaired long-term repopulation capacity, but not short-term, which affects 
lymphoid and myeloid cell lineages (Ito et al., 2004). These defects were caused by increased 
levels of ROS observed in Atm-deficient mice which lead to upregulation of p16, an inhibitor of 
retinoblastoma pathway, and consequently blocking cell cycle progression and HCS self-renewal. 
Treatment with N-acetyl cysteine (NAC), an antioxidant, rescued the phenotype (Ito et al., 2004), 
supporting the notion that oxidative stress regulation by ATM is essential to HSC self-renewal. 
Previous studies showed that BH3-interacting domain death agonist (BID), a proapoptotic 
factor, can be phosphorylated by ATM in response to different stimuli (Kamer et al., 2005; 
Maryanovich et al., 2012). It was shown that BID is phosphorylated by ATM on Ser61 and Ser78 
to induce cell cycle arrest in response to DNA damage (Kamer et al., 2005). Furthermore, another 
study also showed that phosphorylation of Bid by Atm in response to oxidative stress is important 
for HSC modulation between quiescence and proliferation, being this modulation essential to 
prevent HSC exhaustion (Maryanovich et al., 2012). Loss of Bid phosphorylation results in i) 
increase of cell cycle progression and inhibition of self-renewal by upregulating genes involved in 
cell cycle regulation and ii) decrease in the percentage of HSC in G0/quiescence phase. Both 
phenomena lead to the exhaustion of HSC pool (Maryanovich et al., 2012). The absence of 
phosphorylated Bid results in Bid accumulation in the mitochondria and deregulation of ROS 
balance in this organelle (Maryanovich et al., 2012). The administration of NAC restored the 
phenotype (Maryanovich et al., 2012), supporting the notion that, once again, ROS are 
11 
 
responsible for the deregulation of self-renewal and quiescence states and ATM is essential to 
restore this balance.  
In addition, down-regulation of p53 in hematopoietic cells also contributes to the loss of 
quiescence. p53 up-regulates Necdin (Ndn) and Gfi-1, that are involved in quiescence at steady 
state. Loss of ATM and CHK2 down-regulates p53 leading to cell cycle progression with DNA 
errors and loss of quiescence state (Chatterjee et al., 2016). 
Thus, DBS repair and oxidative stress regulation by ATM are essential for a healthy 
hematopoietic compartment and a well-functioning immune response.  
 
1.6 Malaria 
Malaria is a disease caused by the protozoan parasite Plasmodium. According to the World 
Health Organization (WHO) report from 2018, in 2017 the cases of malaria worldwide were about 
219 million resulting in approximately 435 000 deaths (61% of them were children under the age 
of 5 years old). The African region is the most affected with 92% of malaria cases corresponding 
to approximately 95% of the deaths (World Health Organization, 2018). 
There are more than 100 species of Plasmodium and depending on the species, they can 
infect mammals, birds or reptiles. The vector of the parasite is the female Anopheles mosquito 
and there are about 60 species of Anopheles capable of transmitting the disease (Tuteja, 2007). 
Humans can be infected by five species of Plasmodium: P. falciparum, P. vivax, P. ovale, 
P. knowlesi and P. malariae (Garrido-Cardenas et al., 2019). According to WHO data, P. 
falciparum is the most prevalent (World Health Organization, 2018).  
Malaria can be classified as asymptomatic, uncomplicated or severe. In asymptomatic 
cases the patients show no symptoms and therefore no treatment is prescribed. In uncomplicated, 
the patients show symptoms, such as fever, shaking chills, cough, respiratory distress and 
diarrhea, but no major organ dysfunction. In severe malaria, the patients show the same 
symptoms as uncomplicated malaria plus severe anemia and organ damage (specially brain, 
kidneys and lungs) (Garrido-Cardenas et al., 2019; Tuteja, 2007).  
Malaria is a curable disease if treated, and the usual treatment is based on anti-malaria 
drugs, with the most common being artemisinin-based combination therapy, Fansidar and 
chloroquine (Tuteja, 2007; World Health Organization, 2018). Nowadays, the focus is on 
controlling the vector, developing more efficient drugs to overcome parasite resistance and 
developing a functional vaccine to prevent the transmission and evolution of the disease (Tuteja, 
2007). 
 
1.6.1 Life cycle of Plasmodium 
Plasmodium infection in mammals can be divided into two stages: liver stage and blood stage. 
Upon the mosquito bite, the sporozoites, localized in mosquito’s salivary glands, are injected into 
the bloodstream of the host. After reaching the liver, they penetrate the hepatocytes and start 
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asexual reproduction, which represents the liver stage and is also known as exoerythrocytic 
schizogony (Figure 1.4. brown). The invasion occurs due to the binding of thrombospondin 
domains on the circumsporozoite protein (CSP) and thrombospondin-related adhesive protein 
(TRAP) to the heparin sulfate proteoglycans present on hepatocytes (Miller et al., 2002; Tuteja, 
2007). Both CSP and TRAP are sporozoite surface antigens that can be recognized by the 
immune cells and the major target for malaria vaccination. TRAP is also involved in sporozoites 
motility (Weedall et al., 2007). In the hepatocytes, the sporozoites replicate into thousands of 
merozoites that are released to the bloodstream, giving rise to the blood stage of the disease 
(Miller et al., 2002; Tuteja, 2007). 
 
 
 
 
Figure 1.4. Plasmodium life cycle. 
Upon mosquito bite, the sporozoites are injected into the bloodstream of the host where they travel until they 
reach the liver. In the liver, sporozoites penetrate hepatocytes and multiply into merozoites that are 
posteriorly released into the bloodstream. Once in the blood stream, merozoites invade RBC, where they 
can undergo asexual reproduction or sexual reproduction. In asexual reproduction pathway, after invading 
RBC, the merozoite forms a trophozoite. The trophozoite undergo multiple nuclear division without 
cytokinesis forming the schizont. After the lysis of RBC and rupture of the schizont, the merozoites that 
where inside the schizont are released into the bloodstream, where they can invade non-infected RBC again. 
On the sexual reproduction pathway, merozoites differentiate into gametocytes which are ingested by the 
female mosquito once it bites an infected host. On the mosquito’s gut, the gametocytes fuse and form a 
zygote, which develops into an oocyst. After the maturation and rupture of the oocyst, the sporozoites 
migrate to mosquito’s salivary glands and start the cycle again. In red is represented the blood stage of 
infection and the asexual reproduction pathway in RBC; in brown the liver stage and asexual reproduction 
in hepatocytes; and in grey the mosquito stage and sexual reproduction pathway.  
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Once in the bloodstream, merozoites invade red blood cells (RBC), where they can 
undergo asexual or sexual reproduction (Miller et al., 2002; Tuteja, 2007). In the asexual 
reproduction, also known as erythrocytic schizogony (Figure 1.4 red), merozoites invade RBC. 
After invasion, the merozoite forms a trophozoite, also known as the ring form. At this phase, the 
parasite takes advantages of the host’s resources to obtain glucose, performs proteolysis of 
hemoglobin (Hb) to obtain amino acids and ingests host’s cytoplasm to obtain other essential 
nutrients. The trophozoites undergo multiple nuclear divisions without cytokinesis in this way 
forming the schizont, a structure with merozoites inside. After the lysis of RBC and rupture of the 
schizont, between 8 and 32 merozoites are released into the bloodstream, where they can invade 
non-infected RBC, rapidly increasing the number of parasites in each cycle. Another feature of 
the disease is the sequestration and accumulation of infected RBC (iRBC), i. e. RBC infected with 
the parasite at any given moment of the infection, in different organs caused by their adhesive 
properties (Miller et al., 2002; Tuteja, 2007). 
As mentioned, merozoites can also undergo sexual reproduction pathway. In this case 
merozoites differentiate into female or male gametocytes which are ingested by the female 
mosquito once it bites an infected host. In the mosquito’s gut, the gametocytes fuse and form a 
zygote. The zygote penetrates the midgut wall and develops into an oocyst. After the maturation 
and rupture of the oocyst, the sporozoites, that were generated inside, migrate to the mosquito’s 
salivary glands where they can be transmitted to the next host through a blood meal and start the 
cycle again. The process of sexual reproduction is also known as sporogony (Figure 1.4 grey) 
(Miller et al., 2002; Tuteja, 2007).  
The liver stage is asymptomatic and usually the symptoms start during the blood stage, 
after lysis of iRBC and consequent release of cellular contents that trigger the immune response. 
The duration of the cycle varies according to the species of parasite (Tuteja, 2007). 
 
1.6.2 Mouse models of malaria – Plasmodium chabaudi chabaudi 
Rodent models can be used to study human malaria. However, because none of the human 
parasites infect rodents, researchers use different species of Plasmodium but with genetic and 
phenotypic similarities to the human malaria parasites. The Plasmodium species that infect 
rodents are P. chabaudi, P. berghei, P. yoelii and P. vinckei. 
One of the most used species in laboratory is P. chabaudi and the specific cloned line is P. 
chabaudi chabaudi (P. chabaudi chabaudi AS or Pcc). This clone causes synchronous non-lethal 
infection in C57BL/6 mice, where the schizont can adhere to vascular endothelium. The parasite 
genome encodes for Plasmodium interspersed repeat family (PIRS) which are expressed on 
iRBC surface and are important for its adhesion and sequestration. The symptoms of the disease 
start at the peak of infection, which is between days 7 and 10 post infection (with parasitemias 
ranging between 20-50% iRBC). Contrary to the fever observed during human malaria, mice 
develop hypothermia in response to malaria infection. To study blood stage malaria, the parasite 
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can be transmitted from mouse to mouse using blood from infected mice, and in this case no 
vector is needed (Stephens et al., 2012).  
Mice also develop anemia due to lysis of iRBC, suppression of hematopoiesis, clearance 
of uninfected RBC by phagocytosis and dyserythropoeisis. All these phenomena are also seen in 
human malaria. Thus, P. chabaudi chabaudi AS is a good model to study blood stage malaria. In 
C57BL/6 mice, the infection is resolved as the host clears the parasite (Stephens et al., 2012). 
 
1.6.3 Malaria infection and heme 
To obtain the necessary amino acids for their growth, parasites digest around 80% of the Hb 
present in RBC. During Hb proteolysis, besides the amino acids, there is also the release of heme 
(Moore et al., 2006). Heme is the prosthetic group of hemoproteins, such as hemoglobin and 
myoglobin, and is composed by a tetrapyrrole protoporphyrin IX ring and an iron atom (Gozzelino 
et al., 2010).  Heme is catabolized by heme oxygenase 1 (Ho-1), leading to the production of 
carbon monoxide, biliverdin and labile iron (Gozzelino et al., 2010). Although essential to life, iron 
can be toxic to cells, accumulating into labile iron pool (Muckenthaler et al., 2017). To counter 
this, iron can be up taken by ferritin, a multimeric complex, composed by a light and an heavy 
chain, that detoxifies the iron by converting Fe2+ into Fe3+ and then store it (Gozzelino et al., 2010; 
Harrison and Arosio, 1996). 
Plasmodium’s HO-1(PfHO) amino acids sequence is not similar to the one observed in 
mammalian HO-1 and in all the heme-degrading enzymes, and its function is not analogous 
(Okada, 2009; Sigala et al., 2012). While a study reports no activity of PfHO regarding heme 
degradation (Sigala et al., 2012), another study shows that PfHO is involved in the conversion of 
heme into bilirubin supporting the notion that PfHO plays a role in heme catabolism (Okada, 
2009). 
The major pathway of heme detoxification by Plasmodium parasite is the conversion into 
hemozoin (Hz). In order to prevent heme toxicity for the parasite, upon digestion of Hb by 
Plasmodium, heme is immediately converted into Hz. Hz is an insoluble crystal formed in the 
digestive vacuole of the parasite (Moore et al., 2006).  When the schizont rupture occurs, Hz is 
released, together with merozoites, and is immediately removed by phagocytosis. Both lysed 
RBC and Hz are mainly phagocytosed in the liver in mice (Deroost et al., 2014). The amount of 
Hz present in the iRBC depends on the stage of the life cycle of the parasite. In the trophozoite 
stage the levels of Hz are low and in the schizont the levels are high (Moore et al., 2006). Upon 
the lysis of the iRBC, the non-digested Hb is also released to the bloodstream. 
Hb at steady state is a tetramer in the reduced form (Fe2+), however cell-free Hb, when in 
contact with free radicals, dissociates into dimers and is readily oxidized into methemoglobin 
(Fe3+) with the consequent release of heme (Gozzelino et al., 2010). 
Even though heme is an essential molecule for life, in higher concentrations in the plasma 
can be prooxidant, cytotoxic and pro-inflammatory (Larsen et al., 2012). Because of the presence 
of an iron atom, it can be involved in the production of ROS by the Fenton chemistry (Larsen et 
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al., 2012). Fenton chemistry refers to the conversion of hydrogen peroxide into hydroxyl radicals, 
i.e. powerful oxidants, using the iron atom to catalyze the reaction. It can also induce programmed 
cell death in non-hematopoietic cells, compromising the integrity and function of tissues (Larsen 
et al., 2012). Since heme has a lipophilic structure, it can intercalate into the cell membranes, 
thus allowing heme to reach the nucleus and cause DNA damage through ROS production (Aft 
and Mueller, 1983). In addition, heme leads to lipid and protein peroxidation (Aft and Mueller, 
1984; Vincent et al., 1988). 
Under normal conditions, cell-free Hb is recognized and bound by haptoglobin, preventing 
its oxidization (Gozzelino et al., 2010). When the oxidization of Hb occurs, with the consequent 
release of heme, there are mechanisms to avoid accumulation of heme in the plasma, as well as 
the production of ROS, and prevent the damage they may cause (Gozzelino et al., 2010; Larsen 
et al., 2012). For example, apart from the predominant role of HO-1 in heme catabolism, some 
hemoproteins, like albumin and hemopexin, can bind and sequester heme (Gozzelino et al., 
2010). However, in cases like malaria, where the host defense mechanisms are overwhelmed by 
the excessive hemolysis, heme and Hb accumulate in the plasma leading to oxidative stress and 
tissue damage (Larsen et al., 2012). 
 
1.6.4 Malaria and disease tolerance 
In the last decades, disease tolerance mechanisms have been associated with survival and 
protection to malaria (Cumnock et al., 2018; Gozzelino et al., 2012; Martins et al., 2019; Ramos 
et al., 2019). The excessive hemolysis and consequent accumulation of heme and Hb in the 
plasma are the major features of malaria disease and the main potentiators of tissue damage 
(Larsen et al., 2012). By Fenton chemistry, iron atom released from heme contributes to ROS 
production, leading to general tissue damage, through the oxidation of different macromolecules 
including proteins and DNA (Aft and Mueller, 1983, 1984; Candeias and Wardman, 2013; Larsen 
et al., 2012). Thus, mechanisms to counter these deleterious effects of heme and ROS are critical 
to establish disease tolerance and survival to infection. During infection, mice present sickness 
behavior characterized, for example, by loss of appetite and changes in body temperature. 
Infection impacts on host metabolism and induces changes in energy source (Cumnock et al., 
2018; Vandermosten et al., 2018). Initially, mice use glycogen storage as primary energy source, 
however, together with anorexia of infection, leads to glycogen exhaustion and severe 
hypoglycemia (Cumnock et al., 2018; Vandermosten et al., 2018). In order to prevent severe 
hypoglycemia, fatty acids and ketone bodies are then used as sources of energy (Cumnock et 
al., 2018). Thus, even though this sickness behavior is part of the host defense mechanisms 
against the parasite, it can induce damage and organ dysfunction by decreasing the amount of 
glucose available (Cumnock et al., 2018; Vandermosten et al., 2018). Treatment with glucose 
ameliorated the disease without interfering with pathogen load which shows that glucose confers 
protection against infection through a mechanism of disease tolerance (Cumnock et al., 2018). 
Therefore, both stress and damage responses are important to confer protection against 
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Plasmodium infection, by preventing and repairing tissue damage, redox imbalance and 
hypoglycemia state. Understanding disease tolerance mechanisms may allow to identify potential 
targets for therapeutic approaches. 
The host laboratory had made several contributions to our understanding of disease 
tolerance mechanisms in the context of malaria (Gozzelino et al., 2012; Jeney et al., 2014; Ramos 
et al., 2019; Seixas et al., 2009). Gozzelino and co-workers showed that induction of ferritin, the 
multimeric complex that stores iron, particularly in the liver, allows metabolic adaptation to iron 
overload that is essential to confer tolerance to malaria (Gozzelino et al., 2012). Seixas and co-
workers showed that expression of Ho-1, the heme catabolizing enzyme, in the liver also confers 
protection by preventing hepatic failure (Seixas et al., 2009). Recent work from the host laboratory 
showed that expression of Ho-1 and ferritin in the kidney, more specifically in renal proximal tubule 
epithelial cells, is essential to confer protection against malaria and prevent tissue damage in the 
kidney (Ramos et al., 2019). These studies reveal the importance of controlling heme/iron 
metabolism in order to prevent tissue damage, supporting the notion that stress and damage 
responses are essential to confer disease tolerance. In addition, these studies also support the 
notion that stress and damage sensor proteins in specific organs contribute to protect against 
malaria by promoting organismal homeostasis. 
 
1.7 Aims of the project 
Since heme and ROS induce both oxidative stress and DNA damage, and ATM can act as a DNA 
damage and oxidative stress sensor, it is possible that ATM plays a role in the activation of 
disease tolerance mechanisms, in particular in the context of diseases characterized by excessive 
heme accumulation, such as malaria. Unpublished data from the host laboratory showed that 
Atm-deficient mice are more susceptible to blood stage malaria than wild type controls (Figure 
1.5 A), indicating that ATM plays a role in the response to malaria infection. The percentage of 
iRBC, i. e. parasitemia, is similar comparing Atm-deficient (Atm ko) and Atm wild type (Atm wt) 
control mice (Figure 1.5 B) suggesting that Atm does not impact directly on the pathogen itself 
but confers protection against malaria through a mechanism that confers disease tolerance.  
Knowing that Atm-deficient mice are more susceptible to malaria (Figure 1.5 A) and that 
one of the characteristics of this disease is the elevated levels of heme (Larsen et al., 2012), the 
first hypothesis to be tested in this project is that Atm-deficient cells are more susceptible to heme 
treatment. To test this hypothesis the following specific aims will be addressed: 
- Evaluate the susceptibility of Atm-deficient and wild type mouse embryonic fibroblasts 
to heme treatment; 
- Analyse the expression of DNA damage and oxidative stress marker proteins upon 
heme treatment. 
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Figure 1.5 Atm-deficient mice are more susceptible to Plasmodium chabaudi chabaudi 
(AR. Carlos unpublished data). 
(A) Atm wt (n=5) and Atm ko (n=6) mice were injected with Pcc and survival was monitored over 15 days. 
Statistical significance was determined using Mantel-Cox test. * - p≤0.05. (B) Parasitemia of mice treated as 
in A. (C) γ-H2ax and Gapdh protein expression detected by western blot in the brain (B), liver (Li), spleen(S), 
kidney (K), muscle (M), lung (Lu), and heart (H) of C57BL/6 mice, not infected (-) or 7 days after 
intraperitoneally (i.p.) injection with the malaria-causing agent Plasmodium chabaudi chabaudi (Pcc) (+). 
Data are representative of four mice per group in one experiment. 
 
Since ATM has an important role in the hematopoietic compartment (see 1.5 ATM and the 
hematopoietic compartment) and Plasmodium infection causes DNA damage in the spleen, which 
is part of this compartment (Figure 1.5 C), the second hypothesis to be tested is that mice lacking 
functional Atm in the hematopoietic compartment are more susceptible to the hemolysis caused 
by malaria. To test this hypothesis the following specific aims will be analyzed: 
- Evaluate which organs are more affected by heme, in terms of DNA damage and 
oxidative stress; 
- Characterize mice that lack Atm in the hematopoietic compartment, Vavicre/wtAtmΔ/Δ 
mice; 
- Analyse the susceptibility of Vavicre/wtAtmΔ/Δ mice to Plasmodium chabaudi chabaudi 
infection; 
- Analyse the susceptibility of Vavicre/wtAtmΔ/Δ mice to models of sterile hemolysis. 
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Chapter 2. Methods and Materials 
For more details about reagents, kits, antibodies and media, see Table 2.6 at the end of this 
section. 
Mice 
Atmlox/- mice, kindly provided by F. Alt (Howard Hughes Medical Institute, The Children's Hospital, 
Boston) and Vavicre/wt mice, originally obtained from Jacksons Laboratory (B6.Cg-Commd 10Tg(Vav1-
icre)A2Kio/J, #008610) were intercrossed and bred until the final breeding format Atmlox/wt vs 
Vavicre/wtAtmlox/wt was obtained. Atmlox/wt and Vavicre/wtAtmlox/wt mice were bred at the Instituto 
Gulbenkian de Ciência, Lisboa, Portugal in specific pathogen-free (SPF) conditions to generate 
experimental Vavicre/wtAtmΔ/Δ and control Atmlox/lox and Vavicre/wt mice. All the experiments were 
done using mice, females and males, between 7 and 12 weeks of age.  
 
Mice genotyping 
Genotyping was performed using the tail tip of mice with 3-5 weeks of age. Tail lysis and 
genotyping was conducted using Xpert directXtract PCR Kit, according to the manufacturer’s 
instructions. Details of the PCR program are described on Table 2.1, and the primers described 
on Table 2.2. After PCR, electrophoresis in 1,5 % (w/v) agarose gel was performed. 
 
Table 2.1 PCR program. 
Description of PCR steps for genotyping protocol. 
Step Temperature (ºC) Time 
1 94 2 min 
2 94 20 sec 
3 65 15 sec 
4 68 10 sec 
5 Repeat steps 2-4 for 10 cycles 
6 94 15 sec 
7 60 15 sec 
8 72 10 sec 
9 Repeat steps 6-8 for 28 cycles 
10 72 2 min 
20 
 
Table 2.2 Primers for genotyping. 
Primers used for genotyping protocol. 
Primer Sequence Reference 
Atmlox 2 5’-CATCCTTTAATGTGCCTCCCTTCGCC-3’ Zha et al., 2008 
Atmlox 3 5’-GCCCATCCCGTCCACAATATCTCTGC-3’ Zha et al., 2008 
Vav iCre Fwd 5’-AGATGCCAGGACATCAGGAACCTG-3’ Jacksons Laboratory 
Vav iCre Rev 5’-ATCAGCCACACCAGACACAGA GATC-3’ Jacksons Laboratory 
Generic Cre Internal 
Control Fwd 
5’-CTAGGCCACAGAATTGAAAGATCT-3’ Jacksons Laboratory 
Generic Cre Internal 
Control Rev 
5’- GTAGGTGGAAATTCTAGCATCATCC-3’ Jacksons Laboratory 
  
Deletion check 
Deletion of the Atm allele in the hematopoietic compartment of Vavicre/wtAtmΔ/Δ mice was confirmed 
using blood, spleen, bone marrow and thymus samples. Liver samples were used as negative 
control for deletion. Vavicre/wtAtmΔ/Δ mice have two loxP sites on exons 57 and 58 of Atm gene and 
iCre recombinase expression under the control of the Vav promoter, which results in deletion of 
this fragment of the Atm gene only in the hematopoietic compartment. A volume of approximately 
200 μL of blood was collected in heparin and RNA was extracted using the kit NucleoSpin® RNA 
Blood, according to the manufacturer’s instructions. Spleen, bone marrow, thymus and liver were 
harvested, and RNA was extracted after tissue homogenization. For that, tissues were lysed in 1 
mL of tripleXtractor Reagent for 5 min at room temperature (RT) and disrupted mechanically with 
Tissue Lyser (Tissue Lyser II, Qiagen) using 1 tungsten bead per tube (conditions: two times - 
frequency 30/s and time 3 min) (in the case of bone marrow, disruption was achieved only by 
pipetting). After lysis, 200 μL of chloroform were added to each sample, and then samples were 
vortexed, and incubated 3 min at RT. Following incubation, samples were centrifuged at 12,000 
x g for 15 min at 4ºC to separate the different phases and enable the recovery of the aqueous 
phase, which contains the RNA fraction. The aqueous phase was recovered and transferred into 
a fresh tube. RNA isolation proceeded using the kit NucleoSpin® RNA protocol, according to the 
manufacturer’s instructions. Upon RNA extraction from blood and tissues, RNA was converted 
into cDNA using Transcriptor First Strand cDNA Synthesis Kit or Xpert cDNA Synthesis kit and 
Real-Time qPCR was then performed using iTAqTM Universal SYBR® Green Supermix using the 
primers described in Table 2.3. 
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Table 2.3 Primer for Real-Time qPCR. 
Primers used for Real-Time qPCR to confirm Atm deletion 
Primers Sequence Reference 
Atm Fwd 5’-GAAGTGCAGAAGAATCT-3’ AR Carlos unpublished data 
Atm Rev 5’-TGTAACCGACGATAGAAG-3’ AR Carlos unpublished data 
Arbp0 Fwd 5’-CTTTGGGCATCACCACGAA-3’ Penelova et al., 2005 
Arbp0 Rev 5’-GCTGGCTCCCACCTTGTCT-3’ Penelova et al., 2005 
 
Mouse embryonic fibroblasts 
Mouse embryonic fibroblasts (MEFs) were previously isolated from Atm-deficient embryos (Atm 
ko) and from wild type embryos (Atm wt) at embryonic day 12.5 and cultured in DMEM complete 
medium [DMEM medium supplemented with 10 % Fetal Bovine Serum (FBS) heat inactivated 
and 1 % antibiotics (penincilin-streptomycin); for heat inactivation, FBS was placed 30 min at 
56°C with occasional agitation]. MEFs were kept in an incubator at 37ºC with 5 % CO2 saturation 
and when confluent they were split using Trypsin-EDTA 0.05 %.  
 
Heme treatment 
For heme preparation, hemin was weighed in order to have a 10 mM concentration and then 
dissolved in 25 mL of 0.2 M NaOH. The pH was measured and adjusted to pH 7.4 by slowly 
adding 0.2 M HCl. This solution was centrifuged at 4000 rpm for 15 min at 4°C and then filtered 
through a 70 μM cell strainer. Due to precipitation and for accurate measurement of the final 
concentration of heme, 1 μL of heme was diluted in 1 mL of DMSO (extinction coefficient of hemin 
in DMSO = 85820 M-1cm-1) and absorbance was measured at 405 nm using a spectrophotometer 
(SmartSpec™ 3000, BIO-RAD). The concentration was determined according to the Beer’s Law 
Equation, where Absorbance = concentration of solution (hemin) x path length x extinction 
coefficient (extinction coefficient of hemin in DMSO). 
MEFs were treated with heme using two different conditions: 
Condition 1) MEFs were treated with different concentrations of heme (2.5 μM, 5 μM, 10 
μM, 20 μM and 40 μM) in DMEM media supplemented with 1 % antibiotics, but without serum, or 
left untreated in the same media (control) for 3 h. Upon heme treatment, viability of the cells was 
measured using either a Resazurin Assay or Crystal Violet. For Resazurin Assay, cells were 
incubated at 37ºC for 2 h in 1x resazurin solution diluted in DMEM complete media (Stock solution 
1000x – 10 mg/mL resazurin salt in sterile water), and then fluorescence was measured using 
Victor3 plate reader (Perkin Elmer) at 560 nm excitation wavelength and 615 nm emission 
wavelength. For the Crystal Violet method, 0.5 % crystal violet solution in 20 % methanol was 
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added to cells. After 30 min incubation, crystal violet solution was removed, and cells were 
washed with water and left to air dry. A 50 % acetic acid solution was finally added, and the 
absorbance was determined at 595 nm (Multiskan 60, Thermo Scientific). 
Condition 2) MEFs were treated as in condition 1 but, after heme treatment, were incubated 
with DMEM complete media for 24 h. Upon incubation with DMEM complete media, the viability 
of cells was measured using Resazurin Assay and Crystal Violet as described above. 
 
Hemolysis models 
Three models were used to induce hemolysis: Plasmodium chabaudi chabaudi AS (Pcc) infection, 
administration of Phenylhydrazine (PHZ) and administration of anti-mouse RBC antibodies.  
For the Pcc model, male mice received intra-peritoneally (i.p.) injections with 5x105 
Plasmodium-infected RBC (iRBC) per mouse from infected mice (parasitemia of the donor mouse 
between 10 and 20 %) diluted in PBS 1x. Mice were monitored for 25 days with weight, 
temperature, number of RBC, parasitemia (% of iRBC), parasite density (iRBC per μL; 
Parasitemia x total RBC number) and survival being monitored. Parasitemia was determined by 
optical microcopy (1000x magnification), counting the number of iRBC and the total number of 
RBC in 4 fields of a methanol-fixed and Giemsa-stained blood smear. 
For the PHZ model, female mice were i.p. injected with 10 mg/kg of PHZ at day 0 and 
injected with 50 mg/kg of PHZ sixteen hours after. PHZ was prepared in PBS 1x and the pH was 
adjusted to pH 7.4 – 7.6. Mice were monitored for 14 days and weight, temperature, number of 
RBC and survival were monitored. 
For the antibody model, female mice were i.p. injected, 3 times every other day, with 180 
μg of Rabbit anti-mouse Red Blood Cells IgG fraction, which are antibodies that promote direct 
lysis and agglutination of RBC. Mice were monitored for 11 days and weight, temperature, number 
of RBC and survival were monitored. 
The phenotype observed in Atm-deficient mice (Figure 1.5 A-B) was obtained using males, 
since males have been described to have increased susceptibility to malaria, thus in this study 
male mice were also used. Regarding administration of PHZ and anti-RBC antibodies, female 
mice were used to set up conditions for these models. 
 
Flow cytometry analysis 
The number of RBC monitored in hemolysis models were determined by flow cytometry on a 
FACSCalibur analyzer (BD Biosciences) using a known concentration of 10 μm latex beads. The 
results were analyzed using FlowJo software. 
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SDS-PAGE and western blot 
For SDS-PAGE, samples (cells and organs) were collected in 2x SDS-PAGE sample buffer (20 
% Glycerol, 4 % SDS, 100 mM Tris pH 6.8, 0.02 % Bromophenol blue and 100 mM DTT). Upon 
addition of 2x SDS-PAGE sample buffer, organs were disrupted mechanically using a tungsten 
bead and Tissue Lyser (Tissue Lyser II, Qiagen) (conditions: two times - frequency 30/s and time 
3 min). After that, benzonase was added to both cells and organs in order to digest the nucleic 
acids, and then samples were incubated at RT for 10-20 min. Following incubation, samples were 
heated at 70°C for 10 min and centrifuged at 16,100 x g for 10 min to remove cellular debris and 
the supernatant was transferred to a fresh tube. Protein quantification was performed using 
nanodrop (Nanodrop 2000, Thermo Scientific) through the absorbance measurement at 280 nm.  
For Western Blot, samples were loaded (150 μg of protein - samples from tissues; 60 μg 
of protein - samples from cells) in 8 or 12 % polyacrylamide gel (Table 2.4) and electrophoresed 
using 1x Running Buffer (3.02 g Tris, 14.42 g Glycine, 1 g SDS, 1 L distilled water) in the 
conditions described on Table 2.5. Proteins were then transferred to a PVDF membrane using a 
Trans Blot SD Semi Dry Transfer Cell (BIO-RAD) and Transfer Buffer (5.82 g Tris, 2.93 g Glycine, 
and 1 L distilled water, 4°C) in the conditions described on Table 2.5. The membranes were 
blocked with 5 % dry milk in TBST (20 mM Tris, 150 mM NaCl, 0.1 % Tween20 and distilled water, 
pH 7.4-7.6) and the gel was stained with Coomassie-based Instant Blue to confirm the loading of 
the gel. Membranes were incubated with primary antibodies, described on Table 2.5, diluted in 2 
% bovine serum albumin (BSA) in TBST with 0.02 % sodium azide overnight at 4°C. After washing 
in TBST, membranes were incubated with secondary antibodies diluted in 5 % dry milk in TBST 
for 1 h at RT. After washing in TBST, chemiluminescence was detected by using Supersignal 
WestPico Chemilumnescente Substrate HRP or Supersignal WestFemto Chemilumnescente 
Substrate HRP with a secondary antibody dilution of 1:5000 and 1:50000, respectively. Signal 
was acquired using GE Amersham Image 680 (GE Healthcare), equipped with a Peltier cooled 
Fujifilm Super CCD. 
 
Table 2.4 Composition of polyacrymalide gel 
Final concentration of each reagent for resolving and stacking gel to perform western blot. The solutions 
were prepared in MiliQ H2O. 
Reagents 8% Resolving Gel 12% Resolving gel Stacking Gel 
Acrylamide mix 8 % 12 % 5.1 % 
Tris 0.38 M pH 8.8 0.38 M pH 8.8 0.19 M pH 6.8 
SDS 0.1 % 0.1 % 0.1 % 
APS 0.1 % 0.1 % 0.1 % 
TEMED 0.27 mM 0.27 mM 0.67 mM 
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Table 2.5 Running conditions of SDS-PAGE and transfer conditions of western blot 
Running conditions of the SDS-PAGE protocol and the transfer conditions of the proteins on western blot 
protocol. 
 8 % Gel 12 % Gel 
Running Condition 150 V 1 h 150 V 1 h 30 min 
Transfer Conditions 12 V 30 min 12 V 40 min 
 
Table 2.6 Detailed list of all the reagents, antibodies and media. 
List of reagents, kits, antibodies and media used for this project. The products were categorized according 
to the protocol where they were used. 
Product Description Catalog Number Brand 
Genotyping 
Agarose GRS Agarose GA110.0500 Grisp Research Solutions 
DNA ladder 
O’GeneRuler 1 kb Plus DNA 
Ladder 
11511635 Thermo Fisher Scientific 
Xpert directXtract 
PCR Kit 
Xpert directXtract PCR Kit GE60.0480 Grisp Research Solutions 
RNA extraction    
Chloroform 
Chloroform for gas 
chromatography ECD and 
FID Supravolv® 
102432.1000 Merck 
Heparin 
Heparina 25.000 UI/5mL 
solução injetável heparina 
sódica 
014425-03 LEO Pharma A/S 
iTAqTM Universal 
SYBR® Green 
Supermix 
iTAqTM Universal SYBR® 
Green Supermix 
1725124 
Life Technologies - 
Thermo Fisher Scientific 
NucleoSpin® RNA 
Blood 
NucleoSpin® RNA Blood 12733391 Macherey-Nagel 
NucleoSpin® RNA NucleoSpin® RNA Tissues 12373368 Macherey-Nagel 
Transcriptor First 
Strand cDNA 
Synthesis Kit 
Transcriptor First Strand 
cDNA Synthesis Kit 
04897030001 Roche 
tripleXtractor 
Reagent 
tripleXtractor Reagent GB23.0200 Grisp Research Solutions 
Tungsten beads Tungsten Cabide beads 69997 Qiagen 
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Xpert cDNA 
Synthesis kit 
Xpert cDNA Synthesis kit GK80.0100 Grisp Research Solutions 
Media    
Antibiotics 
Penicillin-Streptomycin 
(10,000 U/mL) 
15140122 ThermoFisher Scientific 
DMEM media 
DMEM, high glucose, 
GlutaMAX™ Supplement 
pyruvate - Gibco 
31966021 ThermoFisher Scientific 
Fetal bovine serum 
Fetal Bovine Serum, 
qualified, E.U.-approved, 
South America origin - Gibco 
10270106 ThermoFisher Scientific 
Trypsin-EDTA 
Trypsin-EDTA (0.05%), 
phenol red - Gibco 
25301 04 ThermoFisher Scientific 
Heme Treatment    
DMSO Dimethyl Sulfoxide D2650-100ml Sigma 
HCl 
Hydrochloric acid, 37%, for 
analysis 
10294190 Fisher Chemical 
Hemin Hemin H651-9 Frontier Scientific 
NaOH 
Sodium Hydroxide pellets GR 
ISO 
1.6498.1000 Millipore 
Resazurin Assay    
Resazurin Resazurin sodium salt R7017 Sigma-Aldrich 
Crystal Violet    
Acetic acid Acetic Acid Glacial 20102.320 VWR Chemicals 
Crystal violet Crystal Violet C0775-25G Sigma-Aldrich 
Hemolysis Models    
Anti-mouse RBC 
antibody 
Rabbit anti-mouse Red Blood 
Cells IgG fraction 
CLAG3840 
 
Cedarlane 
Giemsa 
Corante Giemsa, melhorado, 
R66, Gurr 
350864X VWR Chemicals 
PBS 
(DPBS, Dulbecco’s 
Phosphate Buffered Saline 
14200-067 Gibco 
Phenylhydrazine 
Phenylhydrazine 
hydrochloride ≥99% 
114715-5G Sigma-Aldrich 
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Methanol 
Methanol ROTISOLV® min 
99,9%, GC Ultra Grade 
KK44.1 Roth 
Flow Cytometry    
Latex beads Nominal 10 μm Latex Beads 7502475-AB Beckman Coulter 
Western Blot    
Polyacrylamide 
30% Acrylamide/Bis solution, 
29:1 
1610157 BIO-RAD 
APS 
Ammonium persulfate, 99+% 
for molecular biology, DNase, 
RNase and Protease free 
(Acros original) 
10769081 Acros Organics 
Benzonase 
Benzonase Nuclease HC, 
purity >90% 
71205-3 Millipore 
Bromophenol blue Bromophenol Blue 501D9V07 Promega 
BSA 
Bovin Serum Albumin, 
Fraction V, Low Heavy Metals 
12659-100 Millipore 
DTT Dithiothreitol (DTT) 5g 1610611 BIO-RAD 
Filter paper 
Extra thick blot paper, filter 
paper 
1703966 BIO-RAD 
Glycerol Glycerol, 99+% A16205 Alfa Aesar 
Glycine Glycine for molecular biology A1067.1000 PanReac AppliChem 
Instant blue Instant BlueTM ISB1L Expedeon 
Magnesium chloride 
Magnesium chloride 
hexahydrate, ACS reagent, 
99,0-102,0% 
M9272-500G Sigma-Aldrich 
NaCl Sodium Chloride MB15901 nzytech 
Protein ladder NZYColour Protein Marker II MB09003 nzytech 
PVDF membrane 
Immuno-Blot® PVDF 
Membranes for Protein 
Blotting 
1620177 BIO-RAD 
SDS 
SDS, ultra-pure min. 99% for 
eletrophoresis, plastic 
2326.2 Roth 
SDS solution SDS, 20% solution (w/v) 428018-200ml Calbiochem 
Sodium azide Sodium Azide 71289-50G Sigma-Aldrich 
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Supersignal 
WestPico 
Chemilumnescente 
Substrate HRP 
Supersignal WestPico 
Chemilumnescente Substrate 
HRP 
34087 Thermo Scientific 
Supersignal 
WestFemto 
Chemilumnescente 
Substrate HRP 
Supersignal WestFemto 
Chemilumnescente Substrate 
HRP 
34096 Thermo Scientific 
TEMED 
N,N,N’,N’-
Tetramethylethylenediamine 
T9281-25ml Sigma-Aldrich 
Tris 
Tris(hydroxymethyl) 
aminomethane for molecular 
biology 
33621.260 VWR Chemicals 
Tween-20 
Tween®20, Bioxtra, viscous 
liquid 
P7949-500ml Sigma-Aldrich 
Antibodies (dilutions in brackets)   
anti-Chk2 Mouse anti-Chk-2 (1:1000) 05-649 Millipore 
anti-p53 
Mouse anti-p53 (1:1000) 
(1C12) 
2524 Cell Signaling 
anti-γ-H2ax Mouse anti-ϒ-H2AX (1:2500) 05-636 Millipore 
anti- Ho-1 Rabbit anti- HO-1 (1:1000) SPA-896 Stressgen 
anti-β-Actin Mouse anti-β-Actin (1:5000) A5441 Sigma 
anti-H3 Rabbit anti-H3 (1:1000) 9715 Cell Signaling 
anti-Gapdh Goat anti-GAPDH (1:1000) AB0049-200 SICGEN 
anti-mouse IgG-HRP Goat anti-mouse IgG-HRP 115-035-062 
Jackson 
Immunoresearch Europe 
anti-rabbit IgG-HRP Goat anti-rabbit IgG-HRP 111-035-045 
Jackson 
Immunoresearch Europe 
anti-mouse IgG-HRP Donkey anti-mouse IgG-HRP 715-035-151 
Jackson 
Immunoresearch Europe 
anti-goat IgG-HRP Donkey anti-goat IgG-HRP PA1-28664 Thermo Scientific 
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Chapter 3. Results 
Response of Atm-deficient cells to heme treatment 
ATM has an important role in the response to oxidative stress and to DNA damage (see sections 
1.3 ATM as a DNA damage sensor and its targets and 1.4 ATM as an oxidative stress sensor and 
its target). As previously mentioned, malaria is a disease characterized by extensive hemolysis 
with release of hemoglobin and heme into circulation (Gozzelino et al., 2010; Moore et al., 2006). 
Ferritin and Ho-1, two heme/iron regulators, have been shown by the host laboratory to prevent 
iron-related oxidative stress and lethality in the context of malaria (Gozzelino et al., 2012; Ramos 
et al., 2019; Seixas et al., 2009), supporting the notion that damage and stress sensor proteins 
are important in this context. In addition, unpublished data from the host laboratory also showed 
that Atm-deficient mice are more susceptible to malaria (Figure 1.5 A), suggesting that Atm plays 
an essential protective role in the context of this disease. As heme, a central component in the 
pathogenesis of malaria, can lead to the production of ROS, and consequently to DNA damage 
and oxidative stress (Gozzelino et al., 2010; Larsen et al., 2012), it can be used as a model to 
induce the production of ROS and study Atm activation, as well as the susceptibility of Atm-
deficient cells to oxidative stress and DNA damage caused by ROS. 
To test whether Atm-deficient cells are more susceptible to heme treatment, mouse 
embryonic fibroblasts (MEFs) from wild type embryos (Atm wt) and Atm-deficient embryos (Atm 
ko) were used as model. Atm wt MEFs and Atm ko MEFs were treated with different 
concentrations of heme (2.5 μM, 5 μM, 10 μM, 20 μM and 40 μM) or left untreated for 3 h, after 
which cell viability was measured using the Resazurin Assay (Figure 3.1 A). Alternatively, after 
3 h of heme treatment, cells were incubated in complete media for an additional 24 h period to 
understand if the absence of Atm would affect the recovery of cells upon the stimuli. The viability 
of these cells was again measured by the Resazurin Assay (Figure 3.1B). For these experiments, 
heme was diluted in media without serum to prevent the chelation of heme by hemoproteins 
present in the serum, such as albumin.  
The use of the Resazurin Assay allows the analysis of viability due to the reduction of 
Resazurin into Resorufin (fluorescent compound) in the presence of NADPH and NADH. Thus, 
active cell metabolism increases the levels of NADPH and NADH which reduces the resazurin 
added to the cells and translates into more fluorescence (Riss et al., 2004). For the analysis of 
Resazurin Assay, the fluorescence levels were normalized to the respective controls (untreated 
Atm ko or untreated Atm wt). 
30 
 
 
Figure 3.1. Atm-deficient MEFs are equally susceptible to heme as wild type MEFs. 
(A) MEFs were isolated from Atm-deficient embryos (Atm ko) and from wild type embryos (Atm wt). MEFs 
were treated with different concentrations of heme (2,5 μM, 5 μM, 10 μM, 20 μM and 40 μM) in media without 
serum or left untreated (control) for 3 h. Upon heme treatment, viability of the cells was measured using the 
Resazurin Assay and fluorescence was determined. Graph indicates fluorescence of heme treated cells 
normalized to the respective untreated controls. (B) MEFs were treated as in (A), and after heme treatment, 
were incubated with complete media for 24 h. Upon incubation with complete media, viability of the cells 
was measured using Resazurin Assay and fluorescence was determined. Graph indicates fluorescence of 
heme treated cells normalized to the respective untreated controls. (C) Fluorescence of untreated Atm ko 
and wt MEFs for 3 h and fluorescence of untreated Atm ko and wt MEFs for 3 h with an additional 24 h 
incubation period in complete media in arbitrary units (A.U.). These values were used to normalize the values 
calculated in (A) and (B). 
Data shown as the mean ± SD of 3 independent experiments, each done with 3 to 4 technical replicates. 
Statistical analysis done by Two-way ANOVA with Sidak’s multiple comparisons test. P-value n.s.- not 
significant; *- p≤0.05; ***- p≤0.001 
 
 
As shown in Figure 3.1 A, the difference between the values obtained for cell viability 
between genotypes is not significant considering all the concentrations tested. The viability of the 
cells decreased with the increase of heme concentration in both genotypes, since higher 
concentrations of heme were associated with lower fluorescence (Figure 3.1 A). Thus, Atm ko 
MEFs were equally susceptible to heme treatment as Atm wt MEFs. For both genotypes, 
concentrations of heme higher than 20 μM tend to decrease cell viability with 3 h treatment 
(Figure 3.1 A) and unable a total recovery after a 24 h period in complete media (Figure 3.1 B). 
Interestingly, at 3h time point Atm wt MEFs tend to be more susceptible to 20 μM heme when 
compared to untreated Atm wt MEFs, while Atm ko, although present less viability, were not 
significantly more susceptible than untreated Atm ko MEFs at this concentration. The fact that 
higher concentrations of heme were associated with less cell survival corroborates previous 
findings where excess heme has been shown to be toxic for cells (Aft and Mueller, 1983, 1984; 
Gozzelino et al., 2010; Larsen et al., 2012).  
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The fluorescence of untreated Atm wt MEFs and Atm ko MEFs was analyzed without 
normalization in order to ensure that the initial cellular density was similar between genotypes for 
both time points (Figure 3.1 C). This was also verified by visual observations of the plates, and 
as before, no clear differences were observed between genotypes for both time points. 
Cell’s viability, in both conditions, was also measured using Crystal Violet (Figure 3.2). By 
binding to DNA and proteins of adherent/live cells, crystal violet enables the indirect quantification 
of cell death. Dead cells lose their adherence properties and so they are washed away during the 
washing steps. Thus, less cells on the plate correspond to less staining and absorbance 
(Feoktistova et al., 2016). 
 
Figure 3.2. Crystal Violet measurement of MEFs viability. 
(A) MEFs were isolated from Atm-deficient embryos (Atm ko) and from wild type embryos (Atm wt). MEFs 
were treated with different concentrations of heme (2.5 μM, 5 μM, 10 μM, 20 μM and 40 μM) in media without 
serum or left untreated (control) for 3 h. Upon heme treatment, viability of the cells was measured using 
Crystal Violet and absorbance was determined. Graph indicates absorbance at 595 nm of heme treated cells 
normalized to the respective untreated controls. (B) MEFs were treated as in (A), and after heme treatment, 
were incubated with complete media for 24 h. Upon incubation with complete media, viability of the cells 
was measured using Crystal Violet and absorbance was determined. Graph indicates absorbance at 595 
nm of heme treated cells normalized to the respective untreated controls.  
Data shown as the mean ± SD of 3 independent experiments, each done with 3 to 4 technical replicates. 
Statistical analysis done by Two-way ANOVA with Sidak’s multiple comparisons test.  
 
The results obtained with Crystal Violet showed no significant differences between 
genotypes and no significant differences between all heme concentrations tested (Figure 3.2). 
The results were not in concordance with the results obtained by the Resazurin Assay (Figure 
3.1 A) or by visual observation of the cells regarding the 3 h treatment, possibly due to technical 
problems such as difficulty to maintain alive cells adherence to the wells during the assay. For 
the 24 h treatment (Figure 3.2 B), even though is not significant, it is possible to observe the 
same tendency as in Figure 3.1 B, using the Resazurin Assay. Heme and starvation seemed to 
reduce cell adherence to the plate, which explains the discrepancy observed in both methods, 
and incubation in complete media seemed to restore the ability of the cells to adhere, explaining 
the fact that at 24 h time point the methods have similar results. So, further optimization is 
necessary in order to use Crystal Violet as a method to measure MEFs viability after heme 
treatment. 
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Protein expression after heme treatment in vitro 
Even though Atm ko MEFs were not more susceptible to heme when compared to Atm wt MEFs, 
Atm activation may be important for the DNA damage and oxidative stress responses upon heme 
treatment. To further address the role of Atm activation upon heme treatment, Atm wt MEFs and 
Atm ko MEFs were treated with 20 μM of heme for 3 h or left untreated. Cells were also treated 
with 20 μM of heme for 1h and incubated in complete media for an additional 2 h period to 
understand how the recovery process after the stimuli affected the protein expression. Cells were 
then collected and prepared to proceed with western blot (Figure 3.3). The concentration of 20 
μM heme was chosen because it was a concentration that had an intermediate impact on cell’s 
viability in both genotypes (Figure 3.1). 
 
Figure 3.3 Atm-deficiency alters γ-H2ax and p53 protein expression upon heme treatment. 
Atm wt and Atm ko MEFs were treated with 20 μM of heme for 3 h, left untreated for 3h or treated for 1h and 
incubated in complete media for an additional 2h period (1+2). Protein expression of p53, Ho-1, and γ-H2ax 
was determined by western blot. β-actin and histone H3 were used as loading controls. 
Data shown for cells treated for 3h or left untreated is representative of 2 independent experiments and data 
shown for 1h treatment with an additional 2h incubation period in complete media is representative of 1 
independent experiment, but is in accordance with previous data from the host laboratory (AR Carlos, 
unpublished observation). 
 
To evaluate the presence of DNA damage, stabilization of p53 and phosphorylation of 
histone H2ax (γ-H2ax) were determined by western blot. Even though p53 and histone H2ax are 
both Atm targets, they can also be activated by other kinases. Ho-1 was used as a general marker 
for oxidative stress. Histone H3 and β-actin were used as loading controls and showed similar 
loading between all the conditions. 
Regarding p53 expression, the western blot showed that treatment with heme for 3 h does 
not induce the p53 expression when compared to non-treated cells in both genotypes. In the 
second treatment scheme (1+2), after the incubation period of 2 h in complete media, p53 
expression showed an induction in Atm wt MEFs, but this induction seems to be reduced in Atm 
ko MEFs (Figure 3.3). 
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γ-H2ax is induced when cells were treated for 3 h with 20 μM of heme in both genotypes, 
indicating an increase in DNA damage. However, Atm ko MEFs seemed to have less induction 
when compared to Atm wt MEFs. Treatment for 1 h followed by 2 h incubation in complete media 
(1+2) did not show phosphorylation of H2ax (Figure 3.3). In addition, Atm ko MEFs seemed to 
have less basal phosphorylation of H2ax when compared to Atm wt MEFs. 
As expected due to its role in heme catabolism and detoxification, Ho-1 expression levels 
increased in heme- treated cells (Fraser et al., 2011; Gozzelino et al., 2010). Ho-1 induction was 
similar between genotypes in all conditions. Heme-treated cells for 1 h followed by incubation in 
complete media showed more induction of Ho-1 than cells treated with heme for 3 h (Figure 3.3). 
 
Heme treatment in vivo 
The results obtained in vitro (Figure 3.3) showed activation of DNA damage responses 
when cells were treated with heme, so the following step was to understand if heme could also 
cause activation of these responses in vivo. In order to test which organs were more affected by 
heme treatment in vivo, wild type mice were treated with two doses of 20 mg/kg of heme, 12 hours 
apart, or with PBS. Mice were then sacrificed, and brain, liver, spleen, kidney, muscle, lung and 
heart were harvested. Protein expression of DNA damage and oxidative stress markers was 
analyzed by western blot (Figure 3.4), similar to the analysis for heme treatment in vitro (Figure 
3.3). Protein analysis by western blot (Figure 3.4) revealed that heme treatment did not induce 
the expression of p53 in any of the organs analyzed. In fact, kidney, heart and liver showed higher 
expression of p53 in PBS-treated mice when compared to the heme-treated group. 
 
Figure 3.4 Heme treatment induces DNA damage and oxidative stress in vivo. 
Mice were treated with 2 i.p. injections of PBS (-) or 20 mg/kg of heme (+), 12 hours apart, and then brain 
(B), liver (Li), Spleen (S), kidney (K), muscle (M), lung (Lu) and heart (H) were harvested. The organs were 
processed, and protein expression of γ-H2ax, Ho-1, p53 and Chk2 was analyzed by western blot. Histone 
H3, Gapdh and p97 were used as loading controls. 
Data shown is representative of 2 mice per group, 1 independent experiment. 
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Ho-1 expression was induced in liver, spleen, kidney, muscle, lung and heart after heme 
treatment (Figure 3.4), consistent with increased heme catabolism in the presence of excess 
heme (Gozzelino et al., 2010). The spleen showed higher basal expression of Ho-1 when 
compared to the other organs of PBS-treated mice, consistent with what has been described in 
the literature, possible due to spleen’s role in degrading damaged and aged RBC (Choi and Alam, 
1996; Fraser et al., 2011). 
Regarding γ-H2ax, a marker of DNA damage, the spleen was the only organ with a 
considerable induction of this DNA damage marker when compared to the other organs. 
Expression of Chk2 was only detected in the lung. 
Histone H3, Gapdh and p97 were used as loading controls and showed similar loading 
between all the conditions.  
According to protein expression analysis, heme induced DNA damage in the spleen and 
increased heme catabolism in kidney, spleen, liver, lung and heart, suggestive of increased 
oxidative stress.  
 
Vavicre/wtAtmΔ/Δ mice characterization 
Atm-deficiency was previously shown to have an impact on the development and function of 
hematopoietic cells (Balestrini et al., 2016; Barlow et al., 1996; Boultwood, 2001; Chatterjee et 
al., 2016; Ito et al., 2004; Liyanage et al., 2000; Maryanovich et al., 2012; Vacchio et al., 2007) 
(see 1.6 ATM and the hematopoietic compartment), which results in immunodeficiency and 
tumors, in particular lymphomas, both in human and mice that have mutations in Atm (Balestrini 
et al., 2016; Barlow et al., 1996). In addition, data in Figure 3.4 and Figure 1.5 C suggest that 
heme and P. chabaudi chabaudi infection, respectively, induce DNA damage in the spleen, which 
is part of the hematopoietic compartment. These observations combined with the unpublished 
data from the host laboratory where it is shown that Atm-deficient mice are more susceptible to 
malaria (Figure 1.5 A) led to the proposal that lack of Atm in the hematopoietic compartment 
affects the response to malaria, possibly compromising survival of the host. 
To accomplish this, Atmlox/- and Vavicre/wt were bred in order to have the final breeding format 
Atmlox/wt vs. Vavicre/wtAtmlox/wt. Atmlox/- mice were generated by genetically inserting two loxP sites, 
DNA sequences recognized by iCre recombinase, flanking the exons 57 and 58 from the Atm 
kinase domain in one allele (Zha et al., 2008). These loxP sites allow for the deletion of the 
fragment between them by iCre recombinase, using this way the Cre-loxP system (Kim et al., 
2018). Vavicre/wt mice express the iCre recombinase under the control of the Vav promoter. Vav is 
a murine gene expressed in progenitor and adult hematopoietic cells, testicular germ cells, 
developing teeth and placental trophoblasts (de Boer et al., 2003). Studies using regulatory 
elements from Vav promoter controlling specific genes show that the Vav promoter regulates Vav 
gene expression in stem cells, progenitors and mature cells  from the hematopoietic compartment 
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(Balestrini et al., 2016; Georgiades et al., 2002). The Vav promoter also induces a low expression 
of downstream genes in vascular endothelium cells (Georgiades et al., 2002). 
Then, Atmlox/wt and Vavicre/wtAtmlox/wt mice were bred to obtain experimental mice 
Vavicre/wtAtmΔ/Δ and control Vavicre/wt and Atmlox/lox mice. Vavicre/wtAtmΔ/Δ mice are Atm-deficient in 
the hematopoietic compartment from birth due to the constitutive expression of iCre in this 
compartment, under the control of Vav promoter. The generation of these mice enables the study 
of Atm role in the hematopoietic compartment in different contexts, such as malaria and sterile 
hemolysis. 
Though Vavicre/wtAtmΔ/Δ mice have been previously generated in the context of other studies 
(Balestrini et al., 2016; Ehrlich et al., 2015), they have never been characterized. So, before 
starting to use these mice to study the role of Atm during malaria, a characterization was done. 
This characterization was important to ensure that the deletion of Atm only in the hematopoietic 
compartment was efficient and that weight, fertility and genotype distribution would not affect the 
results of the experiments where these mice were used. 
All mice were genotyped using PCR and specific primers for Atm and Vav regions as well 
as interleukin 2 (IL-2) region (internal control). Figure 3.5 shows the PCR analysis of the different 
genotypes generated in the colony Vavicre/wtAtmlox/wt. 
 
Figure 3.5 Genotyping of mice from the breeding pair Vavicre/wtAtmlox/wt vs Atmlox/wt. 
Mice from the breeding pair Vavicre/wtAtmlox/wt vs Atmlox/wt were genotyped by PCR, using primer for Vav and 
Atm regions, and the results visualized by electrophoresis in 1,5% (w/v) agarose gel. (A) Detection of the 
Vav promoter construct by PCR. Top band is an internal control and bottom band correspond to the Vav 
promoter. M- Molecular Marker (O’GeneRuler 1 kb Plus DNA Ladder); 1,2,3- wt; 4,5- Vavicre/wt; 6,7- wt; 8- 
Vavicre/wt; wt- wt control; Vav- Vavicre/wt control; B- Blank (B) Detection of the flox Atm allele by PCR. Top 
band correspond to a flox allele and bottom band correspond to a wt allele. M- Molecular Marker Marker 
(O’GeneRuler 1 kb Plus DNA Ladder); 1- Atmwt; 2- Atmlox/wt; 3- Atmlox/lox; 4- Atmwt; 5- Atmlox/wt; 6- Atmlox/lox; 7- 
Atmwt; 8- Atmlox/lox; wt- wt control; lox/wt- Atmlox/wt control; lox/lox- Atmlox/lox control; B- Blank. 
Each sample was loaded in duplicate. 
 
36 
 
Insertion of DNA encoding the iCre recombinase with Vav promotor (Figure 3.5 A) was 
detected by the appearance of a 236 bp band, as depicted for mice 4,5 and 8, however if the mice 
are wt  this band is absent, as depicted for mice 1,2,3,6 and 7. To ensure that absence of band 
in wt mice was not due to problems with PCR or electrophoresis, internal control primers for the 
IL-2 region were used. Thus, all mice showed a 324 bp band corresponding to the internal control. 
Concerning the Atm allele (Figure 3.5 B), when mice are Atm wt, as mice 1,4 and 7, a 
band with 350 bp appears on the gel. On the other hand, if mice have the Atm gene floxed in both 
alleles, like mice 3,6 and 8 a band with 420 bp appears. Finally, if mice have one Atm allele floxed 
and one wt allele, like mice 2 and 5, two bands appear on the gel, one band corresponding to the 
wt allele (350 bp) and other to the floxed allele (420 bp). 
Thus, mice 1 and 7 are Atmwt, mouse 2 is Atmlox/wt, mice 3 and 6 are Atmlox/lox, mouse 4 is 
Vavicre/wt, mouse 5 is Vavicre/wtAtmlox/wt and mouse 8 is Vavicre/wtAtmΔ/Δ. 
 
To characterize the efficiency of Atm deletion under the control of the Vav promoter, spleen, 
bone marrow, thymus and blood were collected from Vavicre/wtAtmΔ/Δ, Vavicre/wt, Vavicre/wtAtmlox/wt, 
Atmlox/lox and Atmwt mice. Liver was also harvested as a negative control for Atm deletion, since it 
is not a hematopoietic organ. Then, RNA was extracted and converted into cDNA, and mRNA 
expression levels were evaluated using Real-Time qPCR (Figure 3.6). The primers used were 
specific for the region between exons 57 and 58 of Atm, which is part of the kinase domain, so 
that lack of expression would correlate with deletion of this region.  
Atm expression levels in the spleen, bone marrow, thymus and blood were homogeneous 
between Vavicre/wtAtmlox/wt, Vavicre/wt, Atmlox/lox, Atmlox/wt and Atmwt mice while a dramatic reduction 
on Atm expression was observed in Vavicre/wtAtmΔ/Δ mice (Figure 3.6 A-D). As expected, Atm 
expression in the liver was similar between all the mice analyzed (Figure 3.6 E), since it was used 
as a negative control for Atm deletion. Atm expression in Vavicre/wt and Atmlox/lox mice was similar 
to wild type mice for all the organs analyzed, suggesting that these two genotypes can be used 
as controls. So, further experiments to evaluate Atm expression levels in Vavicre/wtAtmΔ/Δ were 
performed focusing just on the experimental mice (Vavicre/wtAtmΔ/Δ) and these two controls.  
To evaluate Atm expression in the controls (Vavicre/wt and Atmlox/lox) and experimental 
(Vavicre/wtAtmΔ/Δ) mice, RNA was extracted from the organs above-mentioned, both from the 
previous experiment and some new ones, and converted into cDNA, for further analysis by Real-
Time qPCR (Figure 3.7). 
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Figure 3.6. Comparison of Atm expression in the spleen, bone marrow, thymus, blood and 
liver in different mouse genotypes.  
Spleen, bone marrow, thymus, blood and liver were collected from Vavicre/wtAtmΔ/Δ, Vavicre/wtAtmlox/wt, 
Vavicre/wt, Atmlox/wt, Atmwt and Atmlox/lox mice and RNA was extracted. The quantification of Atm expression 
was done by Real-Time qPCR and normalized to the housekeeping gene Arbp0. Atm mRNA expression in 
the (A) spleen, (B) bone marrow, (C) thymus, (D) blood and (E) liver. 
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Figure 3.7 Atm expression is significantly reduced in Vavicre/wtAtmΔ/Δ mice in the 
hematopoietic compartment.  
Spleen, bone marrow, thymus, blood and liver were collected from Vavicre/wtAtmΔ/Δ, Vavicre/wt and Atmlox/lox 
mice and RNA was extracted. The quantification of Atm expression was done by Real-Time qPCR and 
normalized first to the housekeeping gene Arbp0 expression. Data expressed relative to the control Atmlox/lox 
mice. Percentage of Atm expression in the (A) spleen, (B) bone marrow, (C) thymus, (D) blood and (E) liver. 
Statistical analysis done by one-way ANOVA. P-value n.s.- not significant; **- p≤0.01; ***- p≤0.001 
In Figure 3.7 are represented some sample from Figure 3.6 and some new ones. 
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Atm expression between the two controls, Vavicre/wt and Atmlox/lox mice, was similar for all 
the organs analyzed. Vavicre/wtAtmΔ/Δ mice showed only 2-5%, 0%, 5-10% and 0% of Atm 
expression in the spleen, bone marrow, thymus and blood, respectively (Figure 3.7 A-D). Atm 
expression was significantly reduced in Vavicre/wtAtmΔ/Δ mice in thymus, spleen and blood. In the 
bone marrow, Atm expression in Vavicre/wtAtmΔ/Δ mice was substantially reduced when compared 
to the control mice however, analysis of more mice would be required to achieve significance. 
Once again, liver was used as a negative control and, as expected, Atm expression in this organ 
was similar in all genotypes (Figure 3.7 E). 
After assessing the efficiency of Atm deletion in the hematopoietic compartment mediated 
by the Vav promoter, further characterization of Vavicre/wtAtmΔ/Δ mice was performed. It is 
described in the literature that Atm-deficient mice have lower weight when compared to wild-type 
mice and heterozygous (Barlow et al., 1996), so the weight at steady state was next characterized. 
The weight of Vavicre/wtAtmΔ/Δ, Vavicre/wtAtmlox/wt, Vavicre/wt, Atmlox/lox, Atmlox/wt and Atmwt mice was 
measured weekly since weaning at 3- to 4-weeks of age and compared to the weight of Atm wild 
type (Atm wt), Atm heterozygous (Atm het) and Atm-deficient mice (Atm ko) (Figure 3.8). 
 
Figure 3.8 Vavicre/wtAtmΔ/Δ have normal weight. 
The weight of Vavicre/wt, Vavicre/wttAtmlox/wt, Vavicre/wtAtmΔ/Δ, Atmwt, Atmlox/wt, Atmlox/lox, Atm wt, Atm het and Atm 
ko mice was followed weekly from weaning at 3 to 4 weeks of age. (A) Weight of males (B) Weight of females 
(C) For easier visualization of results, C reproduces data from A with genotypes Vavicre/wtAtmΔ/Δ, Atmlox/lox, 
Atm wt and Atm ko (D) For easier visualization of results, D reproduces data from B with genotypes 
Vavicre/wtAtmΔ/Δ, Atmlox/lox, Atm wt and Atm ko 
For Males: n=7 Vavicre/wt, n=13 Vavicre/wtAtmlox/wt, n=11 Vavicre/wtAtmΔ/Δ, n= 11 Atmwt, n=13 Atmlox/wt, n=12 
Atmlox/lox, n=13 Atm wt, n=15 Atm het and n= 9 Atm ko. For Females: n=9 Vavicre/wt, n=12 Vavicre/wtAtmlox/wt, 
n=10 Vavicre/wtAtmΔ/Δ, n= 8 Atmwt, n=25 Atmlox/wt, n=16 Atmlox/lox, n=13 Atm wt, n=23 Atm het and n= 10 Atm 
ko. 
Statistical analysis done by one-way ANOVA using Kruskal-Wallis multiple comparison test. P-value *- 
p≤0.05; **- p≤0.01 
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Vavicre/wtAtmΔ/Δ mice, both males and females, had normal weight, with no significant 
differences in weight being observed when compared to that of wild type mice (Figure 3.8 C-D). 
As described in the literature (Barlow et al., 1996), Atm ko mice, both females and males, had 
significantly lower weight when compared to wild type mice (Figure 3.8 C-D).  
Atm-deficient mice have been shown to be infertile (Barlow et al., 1996), so the fertility of 
Vavicre/wtAtmΔ/Δ mice was also investigated. In order to test this, Vavicre/wtAtmΔ/Δ females and male 
were bred with Atmlox/wt males and female, respectively (Table 3.1). Both types of breeding pairs 
had pups, suggesting that Vavicre/wtAtmΔ/Δ females and males are fertile. 
 
Table 3.1 Fertility of Vavicre/wtAtmΔ/Δ mice.  
Vavicre/wtAtmΔ/Δ females and male were bred with Atmlox/wt males and females, respectively, and the presence 
of pups was registered. 
 
 
 Breeding Pairs Format 
Pups 
No of Breeding Pairs Male Female 
1 Vavicre/wtAtmΔ/Δ Atmlox/wt yes 
2 Atmlox/wt Vavicre/wtAtmΔ/Δ yes 
 
Another characteristic of some constitutive Atm mutations is the effect on the observed 
proportions of the genotypes that are born (Barlow et al., 1996; Bishop et al., 2000; Elson et al., 
1996). To evaluate the impact of Atm deletion in Vavicre/wtAtmΔ/Δ, the genotype and gender of each 
pup from the breeding pairs Vavicre/wtAtmlox/wt vs Atmlox/wt and Atm het vs Atm het was register and 
percentages of each genotype, both expected and observed, was calculated (Table 3.2 and 
Table 3.3). 
The percentage of Vavicre/wtAtmΔ/Δ, both males and female, was 7,14 and the total 
percentage of Vavicre/wtAtmΔ/Δ mice was 14,29, similar to the expected 12,5% according to 
Mendel’s distribution. The percentage of Atm ko females was 8,21 and males was 6,71, both 
lower than the expected percentage (12,5%). The percentage of Atm ko mice is lower than the 
expected, although this decrease is not significant.  
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Table 3.2 Number of litters from each genotype and gender born from the breeding pair 
Atm het vs Atm het. 
The genotype and gender of the litters from the breeding pairs Atm het vs Atm het were registered and the 
percentage of expected and observed Atm ko mice was calculated. 
Statistical analysis done by Chi-square test. 
 
 Atm het vs Atm het   
 Males Females  Total 
number 
of pups  wt het ko wt het ko 
 
Observed 24 33 9 19 38 11 
 
134 
Expected 16,75 33,5 16,75 16,75 33,5 16,75   
        
 
 Observed Expected       
Males Atm ko % 6,71 12,50       
Females Atm ko % 8,21 12,50 
      
Total Atm ko % 14,93 25 
      
 
 
Table 3.3 Number of litters from each genotype and gender born from the breeding pair 
Vavicre/wtAtmlox/wt vs Atmlox/wt. 
The genotype and gender of the litters from the breeding pairs Vavicre/wtAtmlox/wt vs Atmlox/wt were registered 
and the percentage of expected and observed Vavicre/wtAtmΔ/Δ mice was calculated. 
Statistical analysis done by Chi-square test.  
 
 
 
Vavicre/wtAtmlox/wt vs Atmlox/wt  
 
 Males  
 
 Vavicre/wt 
Vavicre/wt 
Atmlox/wt 
Vavicre/wt 
AtmΔ/Δ 
Atm wt Atmlox/wt Atm lox/lox  
 
Observed 5 16 12 13 19 13   
Expected 10,5 21 10,5 10,5 21 10,5  Total 
number of 
pups 
        
 Females  168 
 Vavicre/wt 
Vavicre/wt 
Atmlox/wt 
Vavicre/wt 
AtmΔ/Δ 
Atm wt Atmlox/wt Atm lox/lox   
Observed 11 15 12 9 26 17   
Expected 10,5 21 10,5 10,5 21 10,5   
         
 Observed Expected 
Males Vavicre/wtAtmΔ/Δ % 7,14 6,25 
Females Vavicre/wtAtmΔ/Δ % 7,14 6,25 
Total Vavicre/wtAtmΔ/Δ % 14,29 12,5 
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Atm role in the context of malaria 
As mentioned, the aim of this project was to determine if mice Atm-deficient in the hematopoietic 
compartment were more susceptible to hemolytic conditions, such as malaria, than controls. 
To study this, Vavicre/wtAtmΔ/Δ mice and controls, Vavicre/wt and Atmlox/lox mice, were infected 
with Pcc (Plasmodium chabaudi chabaudi AS) and survival, weight, temperature, number of RBC, 
parasitemia and parasite density were monitored for 25 days (Figure 3.9). 
 
 
Figure 3.9 Vavicre/wtAtmΔ/Δ mice are more susceptible to Pcc infection than controls. 
Mice were infected with 5x105 iRBC per mouse, i.p., in PBS and monitored for 25 days regarding (A) survival, 
(B) weight percentage relative to day 0, (C) temperature loss relative to day 0, (D) number of RBC per μL, 
(E) parasitemia and (F) parasite density expressed in iRBC/μL. 
Statistical analysis of (A) done by a long-rank (Mantel-Cox) test and (B), (C), (D), (E) and (F) done by one-
way ANOVA using Kruskal-Wallis multiple comparison test. P-value *- p≤0.05 
 
 
As shown in Figure 3.9 A Vavicre/wtAtmΔ/Δ mice were significantly more susceptible to Pcc 
infection than the controls Vavicre/wt and Atmlox/lox mice. While control mice showed 100% survival, 
only 40% of Vavicre/wtAtmΔ/Δ mice survived the infection. Both Vavicre/wtAtmΔ/Δ and control mice lost 
around 20% of their initial weight (Figure 3.9 B) and decreased between 6 and 10ºC of their initial 
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body temperature (Figure 3.9 C). The decrease in number of RBC started on day 6 and was 
more pronounced around day 10 and Vavicre/wtAtmΔ/Δ had a second decrease around day 21 
(Figure 3.9 D). Both decreases were not significantly different between genotypes. At the peak 
of infection, the parasitemia levels (% of iRBC) reached around 60%, which was between day 7 
and 8 (Figure 3.9 E). Parasitemia levels and parasite density were similar between all genotypes 
(Figure 3.9 E-F), even mice that died reached similar levels of parasitemia as the others, 
suggesting that the function of Atm is related with a mechanism that confers disease tolerance to 
malaria. At day 25, the parasites were cleared, and the infection resolved in all surviving mice, 
except for one Vavicre/wtAtmΔ/Δ mouse, confirmed by the percentage of iRBC (Figure 3.9 E). 
Therefore, Vavicre/wtAtmΔ/Δ mice were more susceptible to malaria infection and the 
protective role of Atm is likely to involve a mechanism that confers disease tolerance to this 
disease. 
 
Atm role in the context of sterile hemolysis 
Having shown that Vavicre/wtAtmΔ/Δ mice are more susceptible to malaria than control mice (Figure 
3.9 A), the question of whether the susceptibility of these mice is due to the parasite itself, or the 
excessive hemolysis and heme release caused by infection, remained. In order to address this 
question, two models of sterile hemolysis, Phenylhydrazine (PHZ) and anti- RBC antibodies, were 
tested. 
PHZ is a well-studied model to induce hemolysis (Berger, 2019; Dutra et al., 2014; Pandey 
et al., 2014). By inducing the production of ROS, PHZ causes oxidation of hemoglobin (Pandey 
et al., 2014). Another mechanism by which PHZ induces hemolysis is by translocating 
phosphatidylserine to the outer membrane of RBC, which signal to induce phagocytosis by 
macrophages. PHZ also increases lipid peroxidation in RBC, iron absorption and activates the 
immune response (Berger, 2019; Dutra et al., 2014; Pandey et al., 2014). The consequences of 
PHZ are more severe in elder animals (Berger, 2019).  
To test the effect of PHZ, Vavicre/wtAtmΔ/Δ, Vavicre/wt, Atmlox/lox and Atmlox/wt mice were i.p.-
injected with 100 mg/kg of PHZ and then with 50 mg/kg of PHZ sixteen hours later, similar to what 
has been previously described (Dutra et al., 2014). Different disease parameters were monitored 
for 14 days, including survival, weight, temperature and number of RBC (Figure 3.10). 
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Figure 3.10. Sterile hemolysis induced by Phenylhydrazine has no effect on Vavicre/wtAtmΔ/Δ 
mice survival. 
Mice were treated with 2 doses of Phenylhydrazine i.p. injection (100 mg/kg on day 0 and 50 mg/kg sixteen 
hour later) and monitored for 14 days in terms of (A) survival, (B) weight percentage relative to day 0, (C) 
temperature loss relative to day 0 and (D) number of RBC per μL. 
Statistical analysis of (A) done by a long-rank (Mantel-Cox) test and (B), (C) and (D) done by one-way 
ANOVA using Kruskal-Wallis multiple comparison test.  
 
As shown in Figure 3.10 A, all mice survived to PHZ treatment. Similarly to malaria 
infection (Figure 3.9 B), Vavicre/wtAtmΔ/Δ and control mice lost about 20% of their initial weight 
(Figure 3.10 B). Regarding temperature, all genotypes dropped around 4°C of body temperature 
compared to the initial temperature (Figure 3.10 C). Decrease in the number of RBC was 
observed around day 4-5, as shown on Figure 3.10 D, and reached values (≈106 RBC) similar to 
the ones observed in the case of malaria infection (Figure 3.9 D). After day 9, all the mice had 
normal levels in all the parameters monitored. Therefore, Vavicre/wtAtmΔ/Δ mice were not more 
susceptible to this dose of PHZ than controls. 
Regarding treatment with anti-RBC antibodies, Vavicre/wtAtmΔ/Δ and control Atmlox/lox mice 
were i.p.-injected with 180 μg of Rabbit anti-mouse Red Blood Cells IgG fraction daily for three 
days, and survival, weight, temperature and number of RBC were monitored for 11 days (Figure 
3.11). 
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Figure 3.11 Effect of antibodies anti-RBC on Vavicre/wtAtmΔ/Δ mice. 
Vavicre/wtAtmΔ/Δ and Atmlox/lox mice were treated with 3 doses of 180 μg Rabbit anti-mouse Red Blood Cells 
IgG fraction and disease parameters were monitored for 11 days including (A) survival, (B) weight 
percentage relative to day 0, (C) temperature loss relative to day 0 and (D) number of RBC per μL. 
Statistical analysis of (A) done by a long-rank (Mantel-Cox) test and (B), (C) and (D) done by t test using 
Mann-Whitney U test.  
 
All mice survived the treatment (Figure 3.11 A), and weight and temperature of all mice 
were normal across the treatment (Figure 3.11 B-C). The number of RBC decreased around day 
5 (Figure 3.11 D), but not to the same levels observed for malaria infection (Figure 3.9 D) and 
PHZ treatment (Figure 3.10 D). Thus, Vavicre/wtAtmΔ/Δ mice were not more susceptible to this 
dosage of anti-RBC antibodies than control Atmlox/lox, but the hemolysis levels observed were 
insufficient. Other doses should be tested to infer about the susceptibility of these mice to 
antibodies anti-RBC treatment. 
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Chapter 4. Discussion 
ATM is a protein kinase involved in DNA repair mechanisms, oxidative stress responses and cell 
cycle regulation, among others (Blackford and Jackson, 2017; Ditch and Paull, 2012; Shiloh and 
Ziv, 2013). Depending on the insult, ATM can be recruited and activated by different proteins and 
induce the activation of many pathways. Upon DSB, ATM is recruited by the MRN complex and 
activated by monomerization to induce DNA repair signaling mechanisms (Bakkenist and Kastan, 
2003; Blackford and Jackson, 2017). However, in the case of oxidative stress caused by ROS 
production, ATM is activated directly through disulfide bonds formation without the involvement 
of the MRN complex and DSB (Guo et al., 2010b; Shiloh and Ziv, 2013). After activation, ATM 
can phosphorylate itself and other substrates such as p53, CHK2 and histone H2AX (Barzilai et 
al., 2002; Blackford and Jackson, 2017; Burma et al., 2001; Shiloh and Ziv, 2013). Mutations in 
the ATM gene are associated with the disease ataxia-telangiectasia (A-T) (Blackford and 
Jackson, 2017). This disease is characterized by chromosomal instability, increased ROS levels 
and increased tumorigenesis, more specifically lymphomas (Balestrini et al., 2016; Reichenbach 
et al., 2002; Shiloh and Ziv, 2013). So, understanding ATM function and target proteins can be 
the missing piece of the puzzle to better understand all features of A-T disease and discover new 
potential therapeutic targets. 
According to unpublished data generated by the host laboratory (Figure 1.5), Atm is 
important in the context of malaria. The Plasmodium parasite is responsible for malaria disease, 
which kills millions of people every year (World Health Organization, 2018). This disease is 
characterized by extensive hemolysis as well as hemoglobin and heme accumulation in the 
plasma (Gozzelino et al., 2012; Larsen et al., 2012). Even though heme is an important molecule, 
when labile and/or in excess it can be pro-oxidant, cytotoxic and pro-inflammatory (Larsen et al., 
2012). By Fenton Chemistry, the iron present in the heme molecule can induce the production of 
ROS originating oxidative stress, which can lead for example to DNA damage (Gonzalez-Hunt et 
al., 2018; Larsen et al., 2012; Sancar et al., 2004). Since Atm can be activated by both oxidative 
stress and DSB to induce stress responses and DNA repair mechanisms, heme, once released 
to the bloodstream, could be the molecule sensed by Atm and the cause of Atm-deficient mice 
susceptibility to malaria infection. 
In order to understand if Atm-deficient cells were more susceptible to heme in vitro, wild 
type and Atm-deficient MEFs were used as models. Treatment with increasing concentrations of 
heme for 3 h with or without an additional 24 h period in complete media showed that 
concentrations of heme equal or higher than 20 μM tend to decrease cell viability (Figure 3.1) 
reinforcing the notion that heme is cytotoxic (Larsen et al., 2012). Viability measurements 
revealed that Atm ko MEFs were not more susceptible to heme than Atm wt MEFs in all heme 
concentrations tested (Figure 3.1). These data suggest that Atm is not essential in the response 
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of MEFs to heme, however they do not exclude the hypothesis that the susceptibility of Atm-
deficient mice to malaria is due to heme release or that Atm is important for other cell types in 
response to heme. Examples of these cells could be hematopoietic cells, such as those present 
in the spleen, that contact with heme upon RBC lysis, leading to increased oxidative stress (Fraser 
et al., 2011), or in brain and nervous system, since Atm ko mice show increased oxidative stress 
in these organs (Kamsler et al., 2001).  
Even though Atm ko MEFs were not more susceptible to heme, the absence of Atm can 
have an impact on protein expression of DNA damage markers, such as stabilization of p53 and 
phosphorylation of histone H2ax, and general oxidative stress markers, such as Ho-1. Protein 
analysis by western blot of Atm ko and Atm wt MEFs treated for 3 h, left untreated or treated for 
1 h with an additional 2 h incubation period in complete media showed that p53 expression is 
induced when cells are treated for 1 h and incubated for 2 h in both genotypes (Figure 3.3). 
However, this induction seemed reduced in Atm ko MEFs. No induction was observed in the 3 h 
time-point for both genotypes. These results are corroborated by a previous study (Shen et al., 
2014) where the authors show that heme can bind to p53, triggering p53 nuclear export as well 
as p53 destabilization and consequent degradation. Since at 3 h time point, the cells were 
harvested with heme still present in the media, it is likely that the balance between p53 activation 
by DNA damage and heme-mediated p53 degradation occurs to a similar extent, preventing the 
observation of p53 induction. In contrast, it is possible to observe p53 induction after 2 h 
incubation in complete media (1+2), which can be explained by the removal of heme two hours 
before collection (Figure 3.3). Protein analysis also revealed that phosphorylation of histone H2ax 
increases after heme treatment in both genotypes, indicating increased DNA damage response 
upon treatment; however, the induction of γ-H2ax in Atm ko MEFs seems to be lower (Figure 
3.3). These data lead to the proposal that Atm plays a role in H2ax phosphorylation and p53 
stabilization in response to heme treatment. Ho-1 expression was also induced after heme 
treatment, as expected, in both genotypes (Fraser et al., 2011; Gozzelino et al., 2010), suggesting 
an increase of heme catabolism in response to heme overload, which seems to be independent 
of the presence of Atm.  
Nevertheless, with these results and time-points it is not possible to conclude if Atm is 
activated by DNA damage directly or indirectly (through the production of ROS) caused by heme 
or by oxidative stress in response to heme. One possible way to understand the mechanism 
behind Atm activation in response to heme would be treating cells for different time-points and 
analyzing which protein and phosphorylations are induced first. 
After concluding that heme increases DNA damage response in both genotypes, but to 
less extent in Atm-deficient cells, and that Ho-1 expression also increases in both genotypes 
(Figure 3.3), the aim was to address in vivo-, which organs were more responsive to heme 
treatment through the induction of DNA damage response and heme catabolism. Protein analysis 
by western blot of brain, liver, spleen, kidney, muscle, lung, heart of wild type mice treated with 
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heme showed induction of Ho-1 expression in the liver, spleen, kidney, muscle, lung and heart, 
indicative of increased heme catabolism. A previous study from the host laboratory (Ramos et al., 
2019) shows induction of Ho-1 expression in liver, spleen, kidney and lung after Plasmodium 
infection. Together, these data support the notion that Plasmodium infection induces Ho-1 
expression in organs through the release of heme. Regarding p53, almost all organs from heme-
treated mice showed a reduction in p53 expression, supporting the notion that heme binds to p53 
and targets it for degradation (Shen et al., 2014). Heme treatment induced phosphorylation of 
H2ax particularly in the spleen, indicative of DNA damage, a result also observed upon Pcc 
infection (Figure 1.5 A).  
Considering that: i) the spleen is part of the hematopoietic compartment; ii) that Atm-
deficient mice and A-T patients have deficiencies associated with this compartment (Balestrini et 
al., 2016; Barlow et al., 1996; Boultwood, 2001; Chatterjee et al., 2016; Ito et al., 2004; Liyanage 
et al., 2000; Maryanovich et al., 2012; Vacchio et al., 2007);  iii) that Atm ko mice are more 
susceptible to malaria infection (Figure 1.5 B); and iv) that Pcc infection and heme treatment 
induce activation of DNA damage responses in the spleen (Figure 1.5 C and Figure 3.4), it is 
possible that the hematopoietic compartment presents higher susceptibility to DNA damage under 
heme-associated diseases, such as malaria and acute hemolysis, and that this susceptibility is 
prevented by Atm. 
To study this hypothesis, Atm-deficient mice in the hematopoietic compartment 
(Vavicre/wtAtmΔ/Δ mice) were generated and characterized. Vavicre/wtAtmΔ/Δ mice showed a 
significantly reduced expression of Atm in the hematopoietic organs (spleen, bone marrow, blood 
and thymus) when compared to controls, Vavicre/wtand Atmlox/lox mice (Figure 3.7 A-D). All mice 
showed similar Atm expression levels in the liver (Figure 3.7 E), organ used as a negative control 
for deletion as it is not part of the hematopoietic compartment. 
Atm-deficient mice were described as having lower weight when compared to wt mice and 
as being infertile due to problems in gametocyte maturation (Barlow et al., 1996), suggesting that 
Atm may have a role in the process of growth and gametocyte maturation. This study revealed 
that Vavicre/wtAtmΔ/Δ mice have normal weight when compared to controls (Figure 3.8) and both 
males and females are fertile (Table 3.1). These observations suggest that Atm deletion in the 
hematopoietic compartment does not play a role in general growth and maturation of 
gametocytes. The hereditary pattern of the Vavicre/wtAtmΔ/Δ genotype was also evaluated, since 
some Atm mutations affect the genotype proportions (Bishop et al., 2000), and the results showed 
that Vavicre/wtAtmΔ/Δ genotype follows Mendel’s distributions (Table 3.3). These observations are 
important for this study in order to exclude any of these characteristics as responsible for Atm ko 
mice susceptibility to malaria infection (Figure 1.5 B). 
At steady state, previous studies have shown that Vavicre/wtAtmΔ/Δ mice have defects in the 
immune compartment (Balestrini et al., 2016; Ehrlich et al., 2015). It has been described in the 
literature that Vavicre/wtAtmΔ/Δ mice have a reduction in the number of thymocytes when compared 
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to wild-type controls, while total number of bone marrow-derived cells remain unaltered (Balestrini 
et al., 2016; Ehrlich et al., 2015), and defects in T-cell development that lead to higher 
predisposition to thymic malignancy (Balestrini et al., 2016; Ehrlich et al., 2015). Despite the 
reduction in the number of thymocytes, thymocyte development does not seem to be affected, 
with cell populations being produced with similar percentages between Vavicre/wtAtmΔ/Δ mice and 
wild-type controls (Balestrini et al., 2016; Ehrlich et al., 2015). Ex-vivo stimulation of spleens from 
Vavicre/wtAtmΔ/Δ mice show defects in the repair of DSB necessary for immunoglobulin CSR, and 
lower levels of IgG when compared to the levels observed in wild type controls (Balestrini et al., 
2016). Further immunological characterization of Vavicre/wtAtmΔ/Δ mice would be important in order 
to evaluate the impact on the response to malaria. 
To study Vavicre/wtAtmΔ/Δ mice susceptibility to malaria, the same Plasmodium strain tested 
in Atm ko mice was used (Plasmodium chabaudi chabaudi AS). The present study showed that 
60% of the Vavicre/wtAtmΔ/Δ mice succumbed to infection, while 100% of the controls survived 
(Figure 3.9 A). Importantly, the parasitemia levels in all the mice reached around 60% regardless 
of the genotype (Figure 3.9 E). These data suggest that Atm plays a protective role by a 
mechanism that confers disease tolerance to infection. Furthermore, Atm may be part of the family 
of proteins required for stress and damage responses to confer protection via disease tolerance 
mechanisms in the context of malaria , such as Ho-1 and ferritin (Gozzelino et al., 2010; Ramos 
et al., 2019; Seixas et al., 2009). Since heme can induce ROS production leading to oxidative 
stress and DNA damage, both types of stimuli can be responsible for Atm activation in the context 
of heme release.  
The hematopoietic compartment includes the thymus, spleen, blood and bone marrow and 
is mainly composed by immune cells. A recent review highlighted the association between 
disease tolerance and immunity (Martins et al., 2019). The authors reveal that, even though 
immune-driven resistance mechanisms can cause immunopathology in response to infection, 
leading to stress and damage in tissues, immune cells can also contribute to repair these stress 
and damage conferring disease tolerance to infection. Data generated in the present study 
suggest that Atm plays a role in stress and damage responses associated with the immune 
compartment (Figure 3.4 and Figure 3.9), supporting the notion that certain immune cells or 
immune-associated mechanisms can confer disease tolerance to infection (Martins et al., 2019). 
Within the immune compartment, Atm can be important in different cells, such as macrophages 
and neutrophils. Macrophages from the spleen, also known as red pulp macrophages (RPM), are 
a type of cells where Atm can play a special role, due to their function in phagocytosis of damaged 
and aged RBC (Kurotaki et al., 2015). The excessive hemolysis and increased amount of 
damaged RBC as a result of malaria, can lead to increased oxidative stress in these cells, making 
Atm necessary to counter the deleterious effects of heme (Aft and Mueller, 1983, 1984; Fraser et 
al., 2011; Larsen et al., 2012; Vincent et al., 1988). In addition, macrophages produce ROS which 
are important for their phagocytic function, making them vulnerable to DNA damage and oxidative 
stress (Bauer et al., 2011; Tan et al., 2016). Thus, Atm can also play a role in repairing DNA 
51 
 
damage and regulating redox homeostasis, in order to prevent macrophages apoptosis and allow 
clearance of damaged RBC. On the other hand, neutrophils can also benefit from Atm-dependent 
disease tolerance mechanisms. Neutrophils are known for NET (neutrophil extracellular trap) 
formation, essential to kill parasites due to their antimicrobial properties (Martins et al., 2019; 
Zychlinsky et al., 2015). However, the components that constitute the NET can be pathogenic for 
the host and lead to chronic inflammation and tissue damage. Thus, neutrophils action is followed 
by apoptosis of these cells to prevent further and unnecessary activation (Martins et al., 2019; 
Zychlinsky et al., 2015). It was recently demonstrated that ROS produced during the oxidative 
burst in neutrophils upon stimulation, activate ATM and DNA damage responses (Zychlinsky et 
al., 2015). The oxidative burst results from the production of superoxide, hydrogen peroxide and 
hypochlorous, via NADPH oxidase, which contributes to kill the parasites (Zychlinsky et al., 2015). 
The authors showed that ATM is activated to down-regulate cytokine productions and signal to 
induce apoptosis, being these two mechanisms not-related (Zychlinsky et al., 2015). A-T patients 
show increased lifespan of neutrophils inflammatory responses as a result of increased cytokine 
production and decreased neutrophil apoptosis (Zychlinsky et al., 2015). Thus, Atm role in the 
context of malaria could be related with the signalling to induce death of neutrophils by apoptosis 
and with down-regulation of cytokine production to inactivate whole neutrophil network and 
prevent chronic inflammation. In keeping with this, programmed cell death can prevent excessive 
stress and damage in the context of inflammatory responses and malaria (Martins et al., 2019). 
In the attempt to test if Vavicre/wtAtmlox/lox mice were also more susceptible to sterile 
hemolysis (hemolysis that is independent of the presence of a parasite) and to show that the 
phenotype observed in malaria would apply to other hemolytic conditions, two models of sterile 
hemolysis were used: phenylhydrazine (PHZ) and antibodies against RBC. PHZ is a chemical 
compound that causes RBC lysis by increasing the production of ROS (Pandey et al., 2014) and 
the anti-RBC antibodies induce direct lysis and agglutination of RBC. 
PHZ-treated mice developed anemia (Figure 3.10 D) and lost about 20% of their initial 
weight (Figure 3.10 B), similarly to malaria infection, however they did not develop hypothermia 
(Figure 3.10 C). In contrast to malaria, Vavicre/wtAtmΔ/Δ mice were not more susceptible to PHZ 
when compared to controls Vavicre/wt and Atmlox/lox mice (Figure 3.10 A). However, it is not possible 
to exclude the possibility that this absence of susceptibility could be dose-related. Another 
possible strategy would be the combination of PHZ treatment with cytokine activation, through 
treatment with lipopolysaccharide (LPS), similar to what has been previously described 
(Fernandez et al., 2010). This way, the inflammatory response activation may increase the 
efficiency of this model, since in the malaria model there is also the inflammation component 
through the recognition of the parasite by the immune compartment. Concerning the model using 
antibodies, this is still being optimized (Figure 3.11). The doses used did not cause anemia or 
changes in any of the disease parameters monitored. Further studies are needed to confirm the 
hypothesis that the phenotype observed in malaria can be applied to other, non-infectious, 
hemolytic conditions. Determination of heme and hemoglobin levels in the plasma could be done 
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as a complementary test to confirm, in all the models used, that the reduction of RBC numbers is 
related with the excessive hemolysis and not with other problems, such as problems in 
erythropoiesis and consequently with the renewal of RBC pool. And also, to confirm that the levels 
of heme released during sterile hemolysis and malaria are similar.  
Altogether, the current study was critical to show that Atm expression in the hematopoietic 
compartment is extremely important in the context of malaria, with the protective role of Atm being 
associated with mechanisms that confer disease tolerance to infection. 
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Chapter 5. Conclusion and Future Perspectives 
Ataxia telangiectasia is a disease characterized by mutations in ATM gene. A-T patients show a 
wide range of symptoms and phenotypes (e.g. higher risk of developing cancer, genomic 
instability and higher levels of oxidative stress). These pleiotropic symptoms can be explained, 
since ATM is involved in many pathways and can be activated by different stimuli. So, the 
knowledge about ATM targets and molecules that trigger ATM activation is essential to demystify 
the role of ATM in different contexts and to possibly discover new therapeutic targets for A-T 
disease. 
 In this project, Atm activation by heme and in the context of hemolytic conditions, such 
as malaria, was studied. Plasmodium parasite, the causative agent of malaria, induces heme 
release through RBC lysis and its accumulation in the plasma. Malaria is responsible for millions 
of deaths every year, especially in African countries, making this disease a global concern. Data 
from the host laboratory suggested that Atm plays a role in the response to malaria (Figure 1.5 
A). In addition, Atm-deficient mice and A-T patients have defects in hematopoietic cells and 
protein analysis of heme-treated mice and Plasmodium infected mice showed induction of DNA 
damage responses in the spleen in both conditions (Figure 1.5 C and Figure 3.4). Altogether, 
these data led to propose a possible role of Atm in the hematopoietic compartment. 
Malaria infection in Vavicre/wtAtmΔ/Δ mice showed that absence of Atm in the hematopoietic 
compartment affects mice survival (Figure 3.9 A). And, lack of differences in parasitemia when 
comparing all groups (Figure 3.9 E), suggests that Atm protective role is associated with 
mechanisms of disease tolerance to infection. The observation supports the notion that Atm-
deficient mice susceptibility to malaria is hematopoietic related.  
This study allowed to identify the hematopoietic compartment as an important 
compartment to confer protection against malaria infection, however the molecular mechanism 
behind this protection is still unknown. Further studies are needed to explore the role of Atm in 
the hematopoietic compartment and the type of cells involved. As previously suggested, 
neutrophils and macrophages may be the cells where Atm role is important to confer disease 
tolerance to infection. Thus, a future experiment with the aim of unraveling the mechanisms and 
cells involved could be Pcc infection of mice that lack Atm only in macrophages and neutrophils. 
After confirming the cell type involved, it would be interesting to study the pathway of Atm 
activation is this context. Vavicre/wtAtmΔ/Δ mice may contribute to shed some light into the molecular 
mechanism and understanding how ATM contributes to confer disease tolerance to hemolytic 
conditions. Optimization of the two sterile-hemolysis models will allow to understand if this 
phenotype can be applied to other non-infectious hemolytic conditions. And, as suggested, the 
combination of PHZ treatment with LPS could be the missing piece for this model to work. To 
better understand all the mechanisms involving ATM responses, it is essential to investigate which 
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pathways lead to Atm activation in response to heme and which are the downstream targets of 
ATM. 
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